{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:02:32Z","timestamp":1792641752508,"version":"4.5.0"},"reference-count":320,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05857-1","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:16:45Z","timestamp":1777259805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer\u2019s Disease: A Recent Review"],"prefix":"10.1007","volume":"63","author":[{"given":"Devesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Babu","family":"Kondaveeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"5857_CR1","doi-asserted-by":"crossref","unstructured":"Rayathala J, Kumar K (2022) Review on Alzheimer\u2019s disease: past, present and future. J Innov Appl Pharm Sci\u00a0(JIAPS) 27:28\u201331","DOI":"10.37022\/jiaps.v7i1.274"},{"key":"5857_CR2","doi-asserted-by":"crossref","unstructured":"Vejandla B, Savani S, Appalaneni R, Veeravalli RS, Gude SS (2024) Alzheimer\u2019s disease: the past, present, and future of a globally progressive disease. Cureus 16(1):e51705","DOI":"10.7759\/cureus.51705"},{"key":"5857_CR3","doi-asserted-by":"crossref","unstructured":"Agrawal M, Singhal M, Mir KB et al (2025) Neuroprotective potential of synephrine against aluminium chloride (AlCl3) induced cognitive impairment & neuronal damage in rats. Pharmacol Res-Mod Chin Med 100680","DOI":"10.1016\/j.prmcm.2025.100680"},{"key":"5857_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH (2021) Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev 65:101208","journal-title":"Ageing Res Rev"},{"key":"5857_CR5","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u MC, Andronie-Cioara FL, Jurc\u0103u A et al (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants 11:2167","journal-title":"Antioxidants"},{"key":"5857_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X et al (2021) The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener 10:45","journal-title":"Transl Neurodegener"},{"key":"5857_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1208\/s12249-024-02923-6","volume":"25","author":"D Shekho","year":"2024","unstructured":"Shekho D, Mishra R, Kamal R et al (2024) Breaking barriers in Alzheimer\u2019s disease: the role of advanced drug delivery systems. AAPS PharmSciTech 25:207","journal-title":"AAPS PharmSciTech"},{"key":"5857_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1570159X17666191113101629","volume":"18","author":"K Chamera","year":"2020","unstructured":"Chamera K, Trojan E, Szuster-G\u0142uszczak M, Basta-Kaim A (2020) The potential role of dysfunctions in neuron-microglia communication in the pathogenesis of brain disorders. Curr Neuropharmacol 18:408\u2013430","journal-title":"Curr Neuropharmacol"},{"key":"5857_CR9","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1007\/s10787-025-01991-9","volume":"33","author":"A Thakur","year":"2025","unstructured":"Thakur A, Sharma R, Sharma R, Devi A (2025) Neurodegeneration and aging: pathophysiology, diagnosis, and therapeutic targets. Inflammopharmacology 33:6485\u20136505","journal-title":"Inflammopharmacology"},{"key":"5857_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.18071\/isz.74.0379","volume":"74","author":"N Bal\u00e1zs","year":"2021","unstructured":"Bal\u00e1zs N, Bereczki D, Kov\u00e1cs T (2021) Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias. Ideggyogy Sz 74:379\u2013387","journal-title":"Ideggyogy Sz"},{"key":"5857_CR11","doi-asserted-by":"crossref","unstructured":"Sridhar GR (2021) Acetylcholinesterase inhibitors (galantamine, rivastigmine, and donepezil). In: Neuro psychopharmacotherapy. Springer International Publishing, Cham, pp 1\u201313","DOI":"10.1007\/978-3-319-56015-1_418-1"},{"key":"5857_CR12","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1002\/ptr.7099","volume":"35","author":"B Chopra","year":"2021","unstructured":"Chopra B, Dhingra AK (2021) Natural products: a lead for drug discovery and development. Phytother Res 35:4660\u20134702","journal-title":"Phytother Res"},{"key":"5857_CR13","doi-asserted-by":"crossref","unstructured":"Govindarajan M (2025) Aquatic environment and types of its ecosystems. In: Aquatic ecotoxicology of legacy pollutants and emerging contaminants: concepts, occurrence, and challenges. Springer Nature Switzerland, Cham, pp 1\u201333","DOI":"10.1007\/698_2024_1174"},{"key":"5857_CR14","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1039\/D0FO03153D","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang Q, Han X et al (2021) Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention. Food Funct 12:3820\u20133830","journal-title":"Food Funct"},{"key":"5857_CR15","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1021\/acschemneuro.3c00460","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun H, Xu L, Wang K et al (2023) \u03ba-carrageenan oligosaccharides protect nerves by regulating microglial autophagy in Alzheimer\u2019s disease. ACS Chem Neurosci 14:3540\u20133550","journal-title":"ACS Chem Neurosci"},{"key":"5857_CR16","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/molecules30051017","volume":"30","author":"W Kruczkowska","year":"2025","unstructured":"Kruczkowska W, Ga\u0142\u0119ziewska J, Grabowska KH et al (2025) From molecules to mind: the critical role of chitosan, collagen, alginate, and other biopolymers in neuroprotection and neurodegeneration. Molecules 30:1017","journal-title":"Molecules"},{"key":"5857_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/md15110322","volume":"15","author":"Q-Q Ouyang","year":"2017","unstructured":"Ouyang Q-Q, Zhao S, Li S-D, Song C (2017) Application of chitosan, chitooligosaccharide, and their derivatives in the treatment of Alzheimer\u2019s disease. Mar Drugs 15:322","journal-title":"Mar Drugs"},{"key":"5857_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/md23030091","volume":"23","author":"C Jia","year":"2025","unstructured":"Jia C, Chai J, Zhang S et al (2025) The advancements of marine natural products in the treatment of Alzheimer\u2019s disease: a study based on cell and animal experiments. Mar Drugs 23:91","journal-title":"Mar Drugs"},{"key":"5857_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/md21010043","volume":"21","author":"D Hu","year":"2023","unstructured":"Hu D, Jin Y, Hou X et al (2023) Application of marine natural products against Alzheimer\u2019s disease: past, present and future. Mar Drugs 21:43","journal-title":"Mar Drugs"},{"key":"5857_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1249018","volume":"10","author":"G Peng","year":"2023","unstructured":"Peng G, Li M, Meng Z (2023) Polysaccharides: potential bioactive macromolecules for Alzheimer\u2019s disease. Front Nutr 10:1249018","journal-title":"Front Nutr"},{"key":"5857_CR21","doi-asserted-by":"crossref","unstructured":"Ravinder K, Kd B, Anjali S, Madhu V, Vijay K, Anurag B (2024) Alzheimer's disease: current landscape and future directions. Int J Sci Res Sci Technol 11(6):28\u201339","DOI":"10.32628\/IJSRST24115100"},{"key":"5857_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"II Babkina","year":"2021","unstructured":"Babkina II, Sergeeva SP, Gorbacheva LR (2021) The role of NF-\u03baB in neuroinflammation. Neurochem J 15:114\u2013128","journal-title":"Neurochem J"},{"key":"5857_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11033-023-09021-z","volume":"51","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Beura SK, Sharma P et al (2024) Oxidative stress in Alzheimer\u2019s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep 51:48","journal-title":"Mol Biol Rep"},{"key":"5857_CR24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/antiox12071371","volume":"12","author":"M Hammad","year":"2023","unstructured":"Hammad M, Raftari M, Ces\u00e1rio R et al (2023) Roles of oxidative stress and Nrf2 signaling in pathogenic and non-pathogenic cells: a possible general mechanism of resistance to therapy. Antioxidants 12:1371","journal-title":"Antioxidants"},{"key":"5857_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140683","volume":"303","author":"M Cai","year":"2025","unstructured":"Cai M, Zhang X, Gao X et al (2025) Chitooligosaccharide ameliorates cognitive deficits and neuroinflammation in APP\/PS1 mice associated with the regulation of Nrf2\/NF-\u03baB axis. Int J Biol Macromol 303:140683","journal-title":"Int J Biol Macromol"},{"key":"5857_CR26","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/ijms25021322","volume":"25","author":"I Benalaya","year":"2024","unstructured":"Benalaya I, Alves G, Lopes J, Silva LR (2024) A review of natural polysaccharides: sources, characteristics, properties, food, and pharmaceutical applications. Int J Mol Sci 25:1322","journal-title":"Int J Mol Sci"},{"key":"5857_CR27","doi-asserted-by":"crossref","unstructured":"Dongre RS (2021) Marine polysaccharides in pharmaceutical uses: chitin, chitosan, alginate, and carrageenan. In: Polysaccharides of microbial origin: biomedical applications. Springer International Publishing, Cham, pp 1\u201335","DOI":"10.1007\/978-3-030-35734-4_43-1"},{"key":"5857_CR28","doi-asserted-by":"crossref","unstructured":"Bedini E, Corsaro MM, Fern\u00e1ndez-Mayoralas A, Iadonisi A (2019) Chondroitin, dermatan, heparan, and keratan sulfate: Structure and functions. In: Extracellular sugar-based biopolymers matrices. Springer International Publishing, Cham, pp 187\u2013233","DOI":"10.1007\/978-3-030-12919-4_5"},{"key":"5857_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/biom11010029","volume":"11","author":"H Sodhi","year":"2020","unstructured":"Sodhi H, Panitch A (2020) Glycosaminoglycans in tissue engineering: a review. Biomolecules 11:29","journal-title":"Biomolecules"},{"key":"5857_CR30","doi-asserted-by":"crossref","unstructured":"Ibrahim HA, El-Sayed WM, El-Sheekh MM (2022) Marine biomaterials: resources, categories, and applications. In: Marine biomaterials: therapeutic potential. Springer Nature Singapore, Singapore, pp 1\u201339","DOI":"10.1007\/978-981-16-5374-2_1"},{"key":"5857_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwae098","volume":"35","author":"AL Felix","year":"2025","unstructured":"Felix AL, Penno SM, Bezerra FF, Mour\u00e3o PAS (2025) Fucosylated chondroitin sulfate, an intriguing polysaccharide from sea cucumber: past, present, and future. Glycobiology 35:cwae098","journal-title":"Glycobiology"},{"key":"5857_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/md19070373","volume":"19","author":"M Silva","year":"2021","unstructured":"Silva M, Seijas P, Otero P (2021) Exploitation of marine molecules to manage Alzheimer\u2019s disease. Mar Drugs 19:373","journal-title":"Mar Drugs"},{"key":"5857_CR33","doi-asserted-by":"publisher","first-page":"1249632","DOI":"10.3389\/fphar.2023.1249632","volume":"14","author":"R Xie","year":"2023","unstructured":"Xie R, Chen F, Ma Y et al (2023) Network pharmacology-based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer\u2019s disease. Front Pharmacol 14:1249632","journal-title":"Front Pharmacol"},{"key":"5857_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Association A","year":"2019","unstructured":"Association A (2019) 2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 15:321\u2013387","journal-title":"Alzheimers Dement"},{"key":"5857_CR35","volume-title":"A blueprint for dementia research","author":"WH Organization","year":"2022","unstructured":"Organization WH (2022) A blueprint for dementia research. World Health Organization"},{"key":"5857_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC et al (2021) Alzheimer disease. Nat Rev Dis Primers 7:33","journal-title":"Nat Rev Dis Primers"},{"key":"5857_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112296","volume":"14","author":"D Nunes","year":"2022","unstructured":"Nunes D, Loureiro JA, Pereira MC (2022) Drug delivery systems as a strategy to improve the efficacy of FDA-approved Alzheimer\u2019s drugs. Pharmaceutics 14:2296","journal-title":"Pharmaceutics"},{"key":"5857_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.25259\/JNRP_356_2023","volume":"14","author":"A Varadharajan","year":"2023","unstructured":"Varadharajan A, Davis AD, Ghosh A et al (2023) Guidelines for pharmacotherapy in Alzheimer\u2019s disease\u2013a primer on FDA-approved drugs. J Neurosci Rural Pract 14:566","journal-title":"J Neurosci Rural Pract"},{"key":"5857_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep11104","volume":"5","author":"T-P Nguyen","year":"2015","unstructured":"Nguyen T-P, Priami C, Caberlotto L (2015) Novel drug target identification for the treatment of dementia using multi-relational association mining. Sci Rep 5:11104","journal-title":"Sci Rep"},{"key":"5857_CR40","first-page":"14","volume":"8","author":"A Panche","year":"2015","unstructured":"Panche A, Chandra S, Diwan AD, Harke S (2015) Alzheimer\u2019s and current therapeutics: a review. Asian J Pharm Clin Res 8:14\u201319","journal-title":"Asian J Pharm Clin Res"},{"key":"5857_CR41","doi-asserted-by":"crossref","unstructured":"Benninghoff J, Perneczky R (2022) Anti-dementia medications and anti-Alzheimer\u2019s disease drugs: side effects, contraindications, and interactions. In: Neuro Psychopharmacotherapy. Springer International Publishing, Cham, pp 1\u201310","DOI":"10.1007\/978-3-319-56015-1_195-1"},{"key":"5857_CR42","doi-asserted-by":"publisher","first-page":"M331","DOI":"10.1093\/gerona\/58.4.M331","volume":"58","author":"GT Grossberg","year":"2003","unstructured":"Grossberg GT, Desai AK (2003) Management of Alzheimer\u2019s disease. J Gerontol A Biol Sci Med Sci 58:M331\u2013M353","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5857_CR43","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/biomedicines9121910","volume":"9","author":"V Garc\u00eda-Morales","year":"2021","unstructured":"Garc\u00eda-Morales V, Gonzalez-Acedo A, Melguizo-Rodr\u00edguez L et al (2021) Current understanding of the physiopathology, diagnosis and therapeutic approach to Alzheimer\u2019s disease. Biomedicines 9:1910","journal-title":"Biomedicines"},{"key":"5857_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Kong G, Yang J et al (2025) Pathological mechanisms and treatment progression of Alzheimer\u2019s disease. Eur J Med Res 30:625","journal-title":"Eur J Med Res"},{"key":"5857_CR45","doi-asserted-by":"crossref","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104(1):103\u2013197","DOI":"10.1152\/physrev.00030.2022"},{"key":"5857_CR46","unstructured":"She X et al (2025) Targeting the synergistic interaction of pathologies in Alzheimer's disease: rationale and prospects for combination therapy. arXiv preprint arXiv:2512.10981"},{"key":"5857_CR47","doi-asserted-by":"crossref","unstructured":"Mallhi TH, Saifullah A, Khan YH, Khan A, Alotaibi NH, Alzarea AI (2021) Pathogenesis of neurodegeneration and associated neurological disorders. In: Environmental contaminants and neurological disorders. Springer International Publishing, Cham, pp 1\u201330","DOI":"10.1007\/978-3-030-66376-6_1"},{"key":"5857_CR48","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U, Rawat P, Reddy AP et al (2022) Amyloid beta in aging and Alzheimer\u2019s disease. Int J Mol Sci 23:12924","journal-title":"Int J Mol Sci"},{"key":"5857_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914794","volume":"24","author":"KS Orobets","year":"2023","unstructured":"Orobets KS, Karamyshev AL (2023) Amyloid precursor protein and Alzheimer\u2019s disease. Int J Mol Sci 24:14794","journal-title":"Int J Mol Sci"},{"key":"5857_CR50","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jcb.30141","volume":"122","author":"P Madhu","year":"2021","unstructured":"Madhu P, Mukhopadhyay S (2021) Distinct types of amyloid-\u03b2 oligomers displaying diverse neurotoxicity mechanisms in Alzheimer\u2019s disease. J Cell Biochem 122:1594\u20131608","journal-title":"J Cell Biochem"},{"key":"5857_CR51","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","volume":"27","author":"L Peng","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W (2022) The synapse as a treatment avenue for Alzheimer\u2019s disease. Mol Psychiatry 27:2940\u20132949","journal-title":"Mol Psychiatry"},{"key":"5857_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/1073858420954811","volume":"27","author":"M Gireud-Goss","year":"2021","unstructured":"Gireud-Goss M, Mack AF, McCullough LD, Urayama A (2021) Cerebral amyloid angiopathy and blood-brain barrier dysfunction. Neuroscientist 27:668\u2013684","journal-title":"Neuroscientist"},{"key":"5857_CR53","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J et al (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841","journal-title":"Int J Mol Sci"},{"key":"5857_CR54","unstructured":"Taddei RN (2024) Understanding the role of glia and oligomeric tau in the early synapse loss of Alzheimer disease dementia. Doctoral dissertation, UCL (University College London)"},{"key":"5857_CR55","doi-asserted-by":"publisher","first-page":"1117172","DOI":"10.3389\/fimmu.2023.1117172","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Zong S, Cui X et al (2023) The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease. Front Immunol 14:1117172","journal-title":"Front Immunol"},{"key":"5857_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B et al (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol 13:856376","journal-title":"Front Immunol"},{"key":"5857_CR57","doi-asserted-by":"publisher","first-page":"4356386","DOI":"10.1155\/2020\/4356386","volume":"2020","author":"K Song","year":"2020","unstructured":"Song K, Li Y, Zhang H et al (2020) Oxidative stress-mediated blood-brain barrier (BBB) disruption in neurological diseases. Oxid Med Cell Longev 2020:4356386","journal-title":"Oxid Med Cell Longev"},{"key":"5857_CR58","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.3390\/ijms23136954","volume":"23","author":"AV Blagov","year":"2022","unstructured":"Blagov AV, Grechko AV, Nikiforov NG et al (2022) Role of impaired mitochondrial dynamics processes in the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 23:6954","journal-title":"Int J Mol Sci"},{"key":"5857_CR59","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M et al (2022) Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett 596:1095\u20131110","journal-title":"FEBS Lett"},{"key":"5857_CR60","unstructured":"Owens L (2024) Chronic stress increases the risk of Alzheimer\u2019s disease"},{"key":"5857_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110995","volume":"133","author":"M Saeedi","year":"2021","unstructured":"Saeedi M, Rashidy-Pour A (2021) Association between chronic stress and Alzheimer\u2019s disease: therapeutic effects of saffron. Biomed Pharmacother 133:110995","journal-title":"Biomed Pharmacother"},{"key":"5857_CR62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1365-2826.1994.tb00635.x","volume":"6","author":"DF Swaab","year":"1994","unstructured":"Swaab DF, Raadsheer FC, Endert E et al (1994) Increased cortisol levels in aging and Alzheimer\u2019s disease in postmortem cerebrospinal fluid. J Neuroendocrinol 6:681\u2013687","journal-title":"J Neuroendocrinol"},{"key":"5857_CR63","volume":"15","author":"S White","year":"2023","unstructured":"White S, Mauer R, Lange C et al (2023) The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 15:e12463","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"5857_CR64","doi-asserted-by":"publisher","DOI":"10.1590\/1980-5764-dn-2023-0031","volume":"17","author":"F Duarte-Zambrano","year":"2023","unstructured":"Duarte-Zambrano F, Barrero JA, Mockus I (2023) Cerebrospinal fluid levels of hypothalamic-pituitary-adrenal axis hormones in MCI and dementia due to Alzheimer\u2019s disease: a systematic review. Dement Neuropsychol 17:e20230031","journal-title":"Dement Neuropsychol"},{"key":"5857_CR65","unstructured":"Abdul-Reda L (2024) Exploring cortisol\u2019s impact on brain structure in late mild cognitive impairments and mild dementia due to probable Alzheimer\u2019s disease. McGill University (Canada)"},{"key":"5857_CR66","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","volume":"26","author":"KN Green","year":"2006","unstructured":"Green KN, Billings LM, Roozendaal B et al (2006) Glucocorticoids increase amyloid-\u03b2 and tau pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci 26:9047\u20139056","journal-title":"J Neurosci"},{"key":"5857_CR67","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/JAD-215546","volume":"86","author":"MA Kelberman","year":"2022","unstructured":"Kelberman MA, Anderson CR, Chlan E et al (2022) Consequences of hyperphosphorylated tau in the locus coeruleus on behavior and cognition in a rat model of Alzheimer\u2019s disease. J Alzheimers Dis 86:1037\u20131059","journal-title":"J Alzheimers Dis"},{"key":"5857_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22317\/jcms.v9i1.1319","volume":"9","author":"KA Alkadhi","year":"2023","unstructured":"Alkadhi KA (2023) Chronic psychosocial stress reveals Alzheimer\u2019s disease in a novel at-risk rat model. J Contemp Med Sci 9:1\u20139","journal-title":"J Contemp Med Sci"},{"key":"5857_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104:103\u2013197","journal-title":"Physiol Rev"},{"key":"5857_CR70","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/antiox10091353","volume":"10","author":"FR Buccellato","year":"2021","unstructured":"Buccellato FR, D\u2019Anca M, Fenoglio C et al (2021) Role of oxidative damage in Alzheimer\u2019s disease and neurodegeneration: From pathogenic mechanisms to biomarker discovery. Antioxidants 10:1353","journal-title":"Antioxidants"},{"key":"5857_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ynstr.2018.04.002","volume":"8","author":"NJ Justice","year":"2018","unstructured":"Justice NJ (2018) The relationship between stress and Alzheimer\u2019s disease. Neurobiol Stress 8:127\u2013133","journal-title":"Neurobiol Stress"},{"key":"5857_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-024-01635-4","volume":"33","author":"G Kannan","year":"2025","unstructured":"Kannan G, Paul BM, Thangaraj P (2025) Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review. Inflammopharmacology 33:145\u2013162","journal-title":"Inflammopharmacology"},{"key":"5857_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","volume":"17","author":"AR Noort","year":"2015","unstructured":"Noort AR, Tak PP, Tas SW (2015) Non-canonical NF-\u03baB signaling in rheumatoid arthritis: dr jekyll and mr hyde? Arthritis Res Ther 17:15","journal-title":"Arthritis Res Ther"},{"key":"5857_CR74","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","volume":"13","author":"MP Mattson","year":"2006","unstructured":"Mattson MP, Meffert MK (2006) Roles for NF-\u03baB in nerve cell survival, plasticity, and disease. Cell Death Differ 13:852\u2013860","journal-title":"Cell Death Differ"},{"key":"5857_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"L Barnabei","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W et al (2021) NF-\u03baB: at the borders of autoimmunity and inflammation. Front Immunol 12:716469","journal-title":"Front Immunol"},{"key":"5857_CR76","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1042\/BCJ20210139","volume":"478","author":"JA Prescott","year":"2021","unstructured":"Prescott JA, Mitchell JP, Cook SJ (2021) Inhibitory feedback control of NF-\u03baB signalling in health and disease. Biochem J 478:2619\u20132664","journal-title":"Biochem J"},{"key":"5857_CR77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S (2009) The NF-\u03baB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5857_CR78","doi-asserted-by":"publisher","first-page":"14290","DOI":"10.1038\/s41598-018-32575-z","volume":"8","author":"H Yano","year":"2018","unstructured":"Yano H, Sakai M, Matsukawa T et al (2018) PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes. Sci Rep 8:14290","journal-title":"Sci Rep"},{"key":"5857_CR79","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/a-1915-4861","volume":"72","author":"A Singh","year":"2022","unstructured":"Singh A, Ansari VA, Mahmood T et al (2022) Neurodegeneration: microglia: Nf-kappab signaling pathways. Drug Research 72:496\u2013499","journal-title":"Drug Research"},{"key":"5857_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P et al (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46:1\u201317","journal-title":"Inflammation"},{"key":"5857_CR81","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.carbpol.2009.10.040","volume":"79","author":"B Eftekharzadeh","year":"2010","unstructured":"Eftekharzadeh B, Khodagholi F, Abdi A, Maghsoudi N (2010) Alginate protects NT2 neurons against H2O2-induced neurotoxicity. Carbohydr Polym 79:1063\u20131072","journal-title":"Carbohydr Polym"},{"key":"5857_CR82","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.3390\/md13095828","volume":"13","author":"R Zhou","year":"2015","unstructured":"Zhou R, Shi X-Y, Bi D-C et al (2015) Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of \u03b2-amyloid. Mar Drugs 13:5828\u20135846","journal-title":"Mar Drugs"},{"key":"5857_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/polym12102338","volume":"12","author":"E Apostolova","year":"2020","unstructured":"Apostolova E, Lukova P, Baldzhieva A et al (2020) Immunomodulatory and anti-inflammatory effects of fucoidan: a review. Polymers 12:2338","journal-title":"Polymers"},{"key":"5857_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13273-017-0045-2","volume":"13","author":"J-W Jeong","year":"2017","unstructured":"Jeong J-W, Hwang SJ, Han MH et al (2017) Fucoidan inhibits lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages and zebrafish larvae. Mol Cell Toxicol 13:405\u2013417","journal-title":"Mol Cell Toxicol"},{"key":"5857_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12640-011-9306-3","volume":"22","author":"P Murgas","year":"2012","unstructured":"Murgas P, Godoy B, Von Bernhardi R (2012) A\u03b2 potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. Neurotox Res 22:69\u201378","journal-title":"Neurotox Res"},{"key":"5857_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020314","volume":"12","author":"X Chen","year":"2023","unstructured":"Chen X, Su J, Wang R et al (2023) Structural optimization of cannabidiol as multifunctional cosmetic raw materials. Antioxidants 12:314","journal-title":"Antioxidants"},{"key":"5857_CR87","doi-asserted-by":"publisher","first-page":"126","DOI":"10.9734\/ijbcrr\/2025\/v34i61071","volume":"34","author":"M Karunanidhi","year":"2025","unstructured":"Karunanidhi M, Subhashini S, Sathya K (2025) Protein kinases: classification, structural dynamics, signalling mechanisms and therapeutic targeting. International Journal of Biochemistry Research & Review 34:126\u2013137","journal-title":"International Journal of Biochemistry Research & Review"},{"key":"5857_CR88","doi-asserted-by":"crossref","unstructured":"Mohan BS, Mahmood AA, Mohammed MQ, Zaki ND (1963) Replicating the MAP kinase cascade in membrane computing. In J Phys: Conf Ser 2021 1963(1):012156","DOI":"10.1088\/1742-6596\/1963\/1\/012156"},{"key":"5857_CR89","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/biom11020173","volume":"11","author":"V Kumar","year":"2021","unstructured":"Kumar V, Maity S (2021) ER stress-sensor proteins and ER-mitochondrial crosstalk\u2014signaling beyond (ER) stress response. Biomolecules 11:173","journal-title":"Biomolecules"},{"key":"5857_CR90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12964-025-02291-z","volume":"23","author":"TM de Toledo","year":"2025","unstructured":"de Toledo TM, Valerio HP, de Melo AT et al (2025) Proteomic analysis of hydrogen peroxide-treated human chondrocytes shows endoplasmic reticulum stress, cytoskeleton remodeling, and altered secretome composition. Cell Communication and Signaling 23:282","journal-title":"Cell Communication and Signaling"},{"key":"5857_CR91","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1523\/JNEUROSCI.18-12-04451.1998","volume":"18","author":"DR McDonald","year":"1998","unstructured":"McDonald DR, Bamberger ME, Combs CK, Landreth GE (1998) \u03b2-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 18:4451\u20134460","journal-title":"J Neurosci"},{"key":"5857_CR92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/glia.10151","volume":"40","author":"M Koistinaho","year":"2002","unstructured":"Koistinaho M, Koistinaho J (2002) Role of p38 and p44\/42 mitogen-activated protein kinases in microglia. Glia 40:175\u2013183","journal-title":"Glia"},{"key":"5857_CR93","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0197-4580(03)00126-X","volume":"25","author":"SH Kim","year":"2004","unstructured":"Kim SH, Smith CJ, Van Eldik LJ (2004) Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1\u03b2 production. Neurobiol Aging 25:431\u2013439","journal-title":"Neurobiol Aging"},{"key":"5857_CR94","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1021\/acschemneuro.9b00271","volume":"10","author":"Z Liang","year":"2019","unstructured":"Liang Z, Zhang B, Xu M et al (2019) 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in Alzheimer\u2019s signaling in human nerve cells. ACS Chem Neurosci 10:4018\u20134030","journal-title":"ACS Chem Neurosci"},{"key":"5857_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01081","volume":"10","author":"D Chang","year":"2019","unstructured":"Chang D, Li H, Qian C, Wang Y (2019) DiOHF protects against doxorubicin-induced cardiotoxicity through ERK1 signaling pathway. Front Pharmacol 10:1081","journal-title":"Front Pharmacol"},{"key":"5857_CR96","first-page":"5170","volume":"11","author":"H-C Lee","year":"2019","unstructured":"Lee H-C, Yu H-P, Liao C-C et al (2019) Escin protects against acetaminophen-induced liver injury in mice via attenuating inflammatory response and inhibiting ERK signaling pathway. Am J Transl Res 11:5170","journal-title":"Am J Transl Res"},{"key":"5857_CR97","doi-asserted-by":"publisher","first-page":"e1019","DOI":"10.1038\/cddis.2013.559","volume":"5","author":"A Sclip","year":"2014","unstructured":"Sclip A, Tozzi A, Abaza A et al (2014) c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis 5:e1019\u2013e1019","journal-title":"Cell Death Dis"},{"key":"5857_CR98","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","volume":"40","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi R, Shahrokhi Nejad S, Falah Tafti M et al (2025) Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease. Metab Brain Dis 40:207","journal-title":"Metab Brain Dis"},{"key":"5857_CR99","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fphys.2019.00516","volume":"10","author":"G Guan","year":"2019","unstructured":"Guan G, Azad MAK, Lin Y et al (2019) Biological effects and applications of chitosan and chito-oligosaccharides. Front Physiol 10:516","journal-title":"Front Physiol"},{"key":"5857_CR100","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijbiomac.2020.04.265","volume":"159","author":"Y Han","year":"2020","unstructured":"Han Y, Ouyang K, Li J et al (2020) Sulfated modification, characterization, immunomodulatory activities and mechanism of the polysaccharides from Cyclocarya paliurus on dendritic cells. Int J Biol Macromol 159:108\u2013116","journal-title":"Int J Biol Macromol"},{"key":"5857_CR101","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/09645284241256669","volume":"42","author":"C Ke","year":"2024","unstructured":"Ke C, Shan S, Tan Y et al (2024) Signaling pathways in the treatment of Alzheimer\u2019s disease with acupuncture: a narrative review. Acupunct Med 42:216\u2013230","journal-title":"Acupunct Med"},{"key":"5857_CR102","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/cells9081897","volume":"9","author":"RD Castro-Torres","year":"2020","unstructured":"Castro-Torres RD, Busquets O, Parcerisas A et al (2020) Involvement of JNK1 in neuronal polarization during brain development. Cells 9:1897","journal-title":"Cells"},{"key":"5857_CR103","first-page":"1997","volume":"19","author":"Y-J Guo","year":"2020","unstructured":"Guo Y-J, Pan W-W, Liu S-B et al (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19:1997\u20132007","journal-title":"Exp Ther Med"},{"key":"5857_CR104","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bpa.12567","volume":"28","author":"C Paquet","year":"2018","unstructured":"Paquet C, Nicoll JAR, Love S et al (2018) Downregulated apoptosis and autophagy after anti-A\u03b2 immunotherapy in Alzheimer\u2019s disease. Brain Pathol 28:603\u2013610","journal-title":"Brain Pathol"},{"key":"5857_CR105","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/2211-5463.13273","volume":"11","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Chen J, Ge X et al (2021) Activation of ERK\u2013Drp1 signaling promotes hypoxia-induced A\u03b2 accumulation by upregulating mitochondrial fission and BACE1 activity. FEBS Open Bio 11:2740\u20132755","journal-title":"FEBS Open Bio"},{"key":"5857_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202207626","volume":"19","author":"F Mohebichamkhorami","year":"2023","unstructured":"Mohebichamkhorami F, Faizi M, Mahmoudifard M et al (2023) Microfluidic synthesis of ultrasmall chitosan\/graphene quantum dots particles for intranasal delivery in Alzheimer\u2019s disease treatment. Small 19:2207626","journal-title":"Small"},{"key":"5857_CR107","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11011-023-01336-x","volume":"39","author":"M Rajkumar","year":"2024","unstructured":"Rajkumar M, Govindaraj P, Vimala K et al (2024) Chitosan\/PLA-loaded magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer\u2019s disease. Metab Brain Dis 39:487\u2013508","journal-title":"Metab Brain Dis"},{"key":"5857_CR108","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ijbiomac.2011.06.014","volume":"49","author":"R Pangestuti","year":"2011","unstructured":"Pangestuti R, Bak S-S, Kim S-K (2011) Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway. Int J Biol Macromol 49:599\u2013606","journal-title":"Int J Biol Macromol"},{"key":"5857_CR109","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms22179592","volume":"22","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci 22:9592","journal-title":"Int J Mol Sci"},{"key":"5857_CR110","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/antiox11081426","volume":"11","author":"T Heurtaux","year":"2022","unstructured":"Heurtaux T, Bouvier DS, Benani A et al (2022) Normal and pathological NRF2 signalling in the central nervous system. Antioxidants 11:1426","journal-title":"Antioxidants"},{"key":"5857_CR111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mad.2009.12.007","volume":"131","author":"M von Otter","year":"2010","unstructured":"von Otter M, Landgren S, Nilsson S et al (2010) Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer\u2019s disease and age-related cataract. Mech Ageing Dev 131:105\u2013110","journal-title":"Mech Ageing Dev"},{"key":"5857_CR112","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.mcn.2008.07.010","volume":"39","author":"K Kanninen","year":"2008","unstructured":"Kanninen K, Malm TM, Jyrkk\u00e4nen H-K et al (2008) Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 39:302\u2013313","journal-title":"Mol Cell Neurosci"},{"key":"5857_CR113","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12640-014-9512-x","volume":"27","author":"H-C Huang","year":"2015","unstructured":"Huang H-C, Hong L, Chang P et al (2015) Chitooligosaccharides attenuate Cu2+-induced cellular oxidative damage and cell apoptosis involving Nrf2 activation. Neurotox Res 27:411\u2013420","journal-title":"Neurotox Res"},{"key":"5857_CR114","doi-asserted-by":"publisher","first-page":"15330","DOI":"10.3390\/ijms232315330","volume":"23","author":"M Acosta-Martinez","year":"2022","unstructured":"Acosta-Martinez M, Cabail MZ (2022) The PI3K\/Akt pathway in meta-inflammation. Int J Mol Sci 23:15330","journal-title":"Int J Mol Sci"},{"key":"5857_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-020-00212-z","volume":"13","author":"J You","year":"2020","unstructured":"You J, Li C, Chen W et al (2020) A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu Gao. BioData Min 13:2","journal-title":"BioData Min"},{"key":"5857_CR116","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3892\/mmr.2017.6342","volume":"15","author":"S Yang","year":"2017","unstructured":"Yang S, Chen Z, Cao M et al (2017) Pioglitazone ameliorates A\u03b242 deposition in rats with diet-induced insulin resistance associated with AKT\/GSK3\u03b2 activation. Mol Med Rep 15:2588\u20132594","journal-title":"Mol Med Rep"},{"key":"5857_CR117","first-page":"4632","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Wang H, Bei J et al (2021) The protective role of miR-132 targeting HMGA2 through the PI3K\/AKT pathway in mice with Alzheimer\u2019s disease. American Journal of Translational Research 13:4632","journal-title":"American Journal of Translational Research"},{"key":"5857_CR118","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2004.04.082","volume":"318","author":"S-Y Hwang","year":"2004","unstructured":"Hwang S-Y, Jung J-S, Lim S-J et al (2004) LY294002 inhibits interferon-gamma-stimulated inducible nitric oxide synthase expression in BV2 microglial cells. Biochem Biophys Res Commun 318:691\u2013697","journal-title":"Biochem Biophys Res Commun"},{"key":"5857_CR119","first-page":"2744","volume":"8","author":"Y He","year":"2013","unstructured":"He Y, Zhou A, Jiang W (2013) Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons. Neural Regen Res 8:2744\u20132753","journal-title":"Neural Regen Res"},{"key":"5857_CR120","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/md15040110","volume":"15","author":"J Wang","year":"2017","unstructured":"Wang J, Liu H, Zhang X et al (2017) Sulfated hetero-polysaccharides protect SH-SY5Y cells from H2O2-induced apoptosis by affecting the PI3K\/Akt signaling pathway. Mar Drugs 15:110","journal-title":"Mar Drugs"},{"key":"5857_CR121","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/md18060333","volume":"18","author":"H Liu","year":"2020","unstructured":"Liu H, Wang J, Zhang Q et al (2020) Protective effect of fucoidan against MPP+-induced SH-SY5Y cells apoptosis by affecting the PI3K\/Akt pathway. Mar Drugs 18:333","journal-title":"Mar Drugs"},{"key":"5857_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152301","volume":"11","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wu X, Yuan H et al (2022) Mitigation of memory impairment with fermented fucoidan and \u03bb-carrageenan supplementation through modulating the gut microbiota and their metagenome function in hippocampal amyloid-\u03b2 infused rats. Cells 11:2301","journal-title":"Cells"},{"key":"5857_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-021-00228-4","volume":"25","author":"BM Lee","year":"2021","unstructured":"Lee BM, Park SJ, Noh I, Kim C-H (2021) The effects of the molecular weights of hyaluronic acid on the immune responses. Biomater Res 25:27","journal-title":"Biomater Res"},{"key":"5857_CR124","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1471-4159.2012.07789.x","volume":"122","author":"JW Austin","year":"2012","unstructured":"Austin JW, Gilchrist C, Fehlings MG (2012) High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation. J Neurochem 122:344\u2013355","journal-title":"J Neurochem"},{"key":"5857_CR125","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12934-020-01417-x","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, Zhu G, Sun C et al (2020) TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2\/STAT3 signaling pathway. Microb Cell Fact 19:158","journal-title":"Microb Cell Fact"},{"key":"5857_CR126","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41374-019-0288-8","volume":"99","author":"DW Kulesza","year":"2019","unstructured":"Kulesza DW, Ramji K, Maleszewska M et al (2019) Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells. Lab Invest 99:1607\u20131621","journal-title":"Lab Invest"},{"key":"5857_CR127","doi-asserted-by":"publisher","first-page":"68654","DOI":"10.18632\/oncotarget.19818","volume":"8","author":"CJ Hwang","year":"2017","unstructured":"Hwang CJ, Choi JY, Park MH et al (2017) KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer\u2019s disease models. Oncotarget 8:68654","journal-title":"Oncotarget"},{"key":"5857_CR128","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2014.03.036","volume":"1563","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Yu L, Hui X et al (2014) Hydroxy-safflor yellow A attenuates A\u03b21-42-induced inflammation by modulating the JAK2\/STAT3\/NF-\u03baB pathway. Brain Res 1563:72\u201380","journal-title":"Brain Res"},{"key":"5857_CR129","doi-asserted-by":"crossref","unstructured":"Zheng ZV, Chen J, Lyu H, Lam SY, Lu G, Chan WY, Wong GK (2022) Novel role of STAT3 in microglia-dependent neuro inflammation after experimental subarachnoid haemorrhage. Stroke Vasc Neurol 7(1):62\u201370","DOI":"10.1136\/svn-2021-001028"},{"key":"5857_CR130","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1523\/JNEUROSCI.0519-10.2010","volume":"30","author":"J Wan","year":"2010","unstructured":"Wan J, Fu AKY, Ip FCF et al (2010) Tyk2\/STAT3 signaling mediates \u03b2-amyloid-induced neuronal cell death: implications in Alzheimer\u2019s disease. J Neurosci 30:6873\u20136881","journal-title":"J Neurosci"},{"key":"5857_CR131","doi-asserted-by":"publisher","first-page":"8489","DOI":"10.1038\/srep08489","volume":"5","author":"A-S Carret-Rebillat","year":"2015","unstructured":"Carret-Rebillat A-S, Pace C, Gourmaud S et al (2015) Neuroinflammation and A\u03b2 accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation. Sci Rep 5:8489","journal-title":"Sci Rep"},{"key":"5857_CR132","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/md17100591","volume":"17","author":"SK Park","year":"2019","unstructured":"Park SK, Kang JY, Kim JM et al (2019) Fucoidan-rich substances from Ecklonia cava improve trimethyltin-induced cognitive dysfunction via down-regulation of amyloid \u03b2 production\/tau hyperphosphorylation. Mar Drugs 17:591","journal-title":"Mar Drugs"},{"key":"5857_CR133","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/nu15082007","volume":"15","author":"S-L Jo","year":"2023","unstructured":"Jo S-L, Yang H, Jeong K-J et al (2023) Neuroprotective effects of Ecklonia cava in a chronic neuroinflammatory disease model. Nutrients 15:2007","journal-title":"Nutrients"},{"key":"5857_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113683","volume":"174","author":"W-J Zhang","year":"2023","unstructured":"Zhang W-J, Li K-Y, Lan Y et al (2023) Nlrp3 inflammasome: a key contributor to the inflammation formation. Food Chem Toxicol 174:113683","journal-title":"Food Chem Toxicol"},{"key":"5857_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1178-5","volume":"15","author":"B-R Wang","year":"2018","unstructured":"Wang B-R, Shi J-Q, Ge N-N et al (2018) PM2. 5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer\u2019s disease. J Neuroinflammation 15:132","journal-title":"J Neuroinflammation"},{"key":"5857_CR136","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"B-Z Shao","year":"2015","unstructured":"Shao B-Z, Xu Z-Q, Han B-Z et al (2015) NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 6:262","journal-title":"Front Pharmacol"},{"key":"5857_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101192","volume":"64","author":"Y-S Feng","year":"2020","unstructured":"Feng Y-S, Tan Z-X, Wu L-Y et al (2020) The involvement of NLRP3 inflammasome in the treatment of Alzheimer\u2019s disease. Ageing Res Rev 64:101192","journal-title":"Ageing Res Rev"},{"key":"5857_CR138","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u2013678","journal-title":"Nature"},{"key":"5857_CR139","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C et al (2020) The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci 117:32145\u201332154","journal-title":"Proc Natl Acad Sci"},{"key":"5857_CR140","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459\u2013472","journal-title":"J Cell Biol"},{"key":"5857_CR141","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.neurobiolaging.2014.12.033","volume":"36","author":"E Turano","year":"2015","unstructured":"Turano E, Busetto G, Marconi S et al (2015) Neurotoxicity and synaptic plasticity impairment of N-acetylglucosamine polymers: implications for Alzheimer\u2019s disease. Neurobiol Aging 36:1780\u20131791","journal-title":"Neurobiol Aging"},{"key":"5857_CR142","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.3390\/ijms24076301","volume":"24","author":"C Russo","year":"2023","unstructured":"Russo C, Valle MS, Casabona A, Malaguarnera L (2023) Chitinase signature in the plasticity of neurodegenerative diseases. Int J Mol Sci 24:6301","journal-title":"Int J Mol Sci"},{"key":"5857_CR143","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.trac.2011.10.014","volume":"34","author":"K Duarte","year":"2012","unstructured":"Duarte K, Rocha-Santos TAP, Freitas AC, Duarte AC (2012) Analytical techniques for discovery of bioactive compounds from marine fungi. TrAC Trends Anal Chem 34:97\u2013110","journal-title":"TrAC Trends Anal Chem"},{"key":"5857_CR144","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1055\/s-0034-1383001","volume":"80","author":"P Kiuru","year":"2014","unstructured":"Kiuru P, D\u02bcAuria MV, Muller CD et al (2014) Exploring marine resources for bioactive compounds. Planta medica 80:1234\u20131246","journal-title":"Planta medica"},{"key":"5857_CR145","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.3390\/md8122906","volume":"8","author":"M Sugumaran","year":"2010","unstructured":"Sugumaran M, Robinson WE (2010) Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin. Mar Drugs 8:2906\u20132935","journal-title":"Mar Drugs"},{"key":"5857_CR146","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/aps.2014.114","volume":"36","author":"DG Nair","year":"2015","unstructured":"Nair DG, Weiskirchen R, Al-Musharafi SK (2015) The use of marine-derived bioactive compounds as potential hepatoprotective agents. Acta Pharmacol Sin 36:158\u2013170","journal-title":"Acta Pharmacol Sin"},{"key":"5857_CR147","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biotechadv.2011.02.002","volume":"29","author":"M Schumacher","year":"2011","unstructured":"Schumacher M, Kelkel M, Dicato M, Diederich M (2011) Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer. Biotechnol Adv 29:531\u2013547","journal-title":"Biotechnol Adv"},{"key":"5857_CR148","doi-asserted-by":"publisher","first-page":"1506789","DOI":"10.3389\/fphar.2024.1506789","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Ren Y, Zhang S et al (2024) Marine-derived polysaccharides: the potential agents against neurodegenerative diseases. Front Pharmacol 15:1506789","journal-title":"Front Pharmacol"},{"key":"5857_CR149","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/0118715249269050231129103002","volume":"24","author":"R Arora","year":"2024","unstructured":"Arora R, Babbar R, Dabra A et al (2024) Marine-derived compounds: a powerful platform for the treatment of Alzheimer\u2019s disease. Central Nervous System Agents in Medicinal ChemistryChemistry-Central Nervous System Agents) 24:166\u2013181","journal-title":"Central Nervous System Agents in Medicinal ChemistryChemistry-Central Nervous System Agents)"},{"key":"5857_CR150","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/nu16244394","volume":"16","author":"M Cokdinleyen","year":"2024","unstructured":"Cokdinleyen M, Dos Santos LC, de Andrade CJ et al (2024) A narrative review on the neuroprotective potential of brown macroalgae in Alzheimer\u2019s disease. Nutrients 16:4394","journal-title":"Nutrients"},{"key":"5857_CR151","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/molecules20022510","volume":"20","author":"C Iannuzzi","year":"2015","unstructured":"Iannuzzi C, Irace G, Sirangelo I (2015) The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity. Molecules 20:2510\u20132528","journal-title":"Molecules"},{"key":"5857_CR152","unstructured":"Redenti S (2017) Design, synthesis and characterization of GSK-3\u03b2 and CK-1\u03b4 inhibitors"},{"key":"5857_CR153","unstructured":"Mycroft-West CJ (2022)\u00a0Non-anticoagulant glycosaminoglycan extracts isolated from aquatic species inhibit bace-1, a keydrug target in Alzheimer's disease. Doctoral dissertation, Keele University"},{"key":"5857_CR154","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 22:9652","journal-title":"Int J Mol Sci"},{"key":"5857_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14010001","volume":"14","author":"M Dhahri","year":"2021","unstructured":"Dhahri M, Alghrably M, Mohammed HA et al (2021) Natural polysaccharides as preventive and therapeutic horizon for neurodegenerative diseases. Pharmaceutics 14:1","journal-title":"Pharmaceutics"},{"key":"5857_CR156","doi-asserted-by":"crossref","unstructured":"Kaur G, Kumar S (2025) Neuroprotective effects of seaweeds in Azheimer's disease: a review. Curr Pharm Res 20:175\u2013187","DOI":"10.63785\/cpr.2025.1.1.137149"},{"key":"5857_CR157","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3892\/mmr.2016.6006","volume":"15","author":"Y Liu","year":"2017","unstructured":"Liu Y, Jiang L, Li X (2017) \u03ba-carrageenan-derived pentasaccharide attenuates A\u03b225\u201335-induced apoptosis in SH-SY5Y cells via suppression of the JNK signaling pathway. Mol Med Rep 15:285\u2013290","journal-title":"Mol Med Rep"},{"key":"5857_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209573","volume":"14","author":"MB Huynh","year":"2019","unstructured":"Huynh MB, Ouidja MO, Chantepie S et al (2019) Glycosaminoglycans from Alzheimer\u2019s disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau. PLoS ONE 14:e0209573","journal-title":"PLoS ONE"},{"key":"5857_CR159","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/md22080336","volume":"22","author":"A Repici","year":"2024","unstructured":"Repici A, Hasan A, Capra AP et al (2024) Marine algae and deriving biomolecules for the management of inflammatory bowel diseases: potential clinical therapeutics to decrease gut inflammatory and oxidative stress markers? Mar Drugs 22:336","journal-title":"Mar Drugs"},{"key":"5857_CR160","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/revneuro-2019-0117","volume":"31","author":"X Yang","year":"2020","unstructured":"Yang X (2020) Chondroitin sulfate proteoglycans: key modulators of neuronal plasticity, long-term memory, neurodegenerative, and psychiatric disorders. Rev Neurosci 31:555\u2013568","journal-title":"Rev Neurosci"},{"key":"5857_CR161","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1039\/D4MH01598C","volume":"12","author":"S Martin-Salda\u00f1a","year":"2025","unstructured":"Martin-Salda\u00f1a S, Al-Waeel M, Bagnoli E et al (2025) Hyaluronic acid-based hydrogels modulate neuroinflammation and extracellular matrix remodelling in multiple sclerosis: insights from a primary cortical cell model. Mater Horiz 12:3841\u20133854","journal-title":"Mater Horiz"},{"key":"5857_CR162","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/1381612825666190618152133","volume":"25","author":"II Muhamad","year":"2019","unstructured":"Muhamad II, Zulkifli N, Selvakumaran S a p, Lazim NAM (2019) Bioactive algal-derived polysaccharides: multi-functionalization, therapeutic potential and biomedical applications. Curr pharm des 25:1147\u20131162","journal-title":"Curr pharm des"},{"key":"5857_CR163","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/phycology5040080","volume":"5","author":"AA Waoo","year":"2025","unstructured":"Waoo AA, Singh S, Chandra N et al (2025) Comprehensive review on the biomedical applications of marine algal polysaccharides. Phycology 5:80","journal-title":"Phycology"},{"key":"5857_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/md15120388","volume":"15","author":"S-Y Xu","year":"2017","unstructured":"Xu S-Y, Huang X, Cheong K-L (2017) Recent advances in marine algae polysaccharides: isolation, structure, and activities. Mar Drugs 15:388","journal-title":"Mar Drugs"},{"key":"5857_CR165","doi-asserted-by":"crossref","unstructured":"Stiger-Pouvreau V, Bourgougnon N, Deslandes E (2016) Carbohydrates from seaweeds. In: Seaweed in health and disease prevention. Academic Press, pp 223\u2013274","DOI":"10.1016\/B978-0-12-802772-1.00008-7"},{"key":"5857_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/md19020089","volume":"19","author":"S Bauer","year":"2021","unstructured":"Bauer S, Jin W, Zhang F, Linhardt RJ (2021) The application of seaweed polysaccharides and their derived products with potential for the treatment of Alzheimer\u2019s disease. Mar Drugs 19:89","journal-title":"Mar Drugs"},{"key":"5857_CR167","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1016\/j.biomaterials.2011.04.024","volume":"32","author":"SK Tusi","year":"2011","unstructured":"Tusi SK, Khalaj L, Ashabi G et al (2011) Alginate oligosaccharide protects against endoplasmic reticulum-and mitochondrial-mediated apoptotic cell death and oxidative stress. Biomaterials 32:5438\u20135458","journal-title":"Biomaterials"},{"key":"5857_CR168","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/md18030144","volume":"18","author":"M Xing","year":"2020","unstructured":"Xing M, Cao Q, Wang Y et al (2020) Advances in research on the bioactivity of alginate oligosaccharides. Mar Drugs 18:144","journal-title":"Mar Drugs"},{"key":"5857_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174056","volume":"29","author":"BS Daraban","year":"2024","unstructured":"Daraban BS, Popa AS, Stan MS (2024) Latest perspectives on Alzheimer\u2019s disease treatment: the role of blood-brain barrier and antioxidant-based drug delivery systems. Molecules 29:4056","journal-title":"Molecules"},{"key":"5857_CR170","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16095","volume":"12","author":"E Mohammadbaghban","year":"2024","unstructured":"Mohammadbaghban E, Taravati A, Najafzadehvarzi H et al (2024) Oral administration of encapsulated catechin in chitosan-alginate nanoparticles improves cognitive function and neurodegeneration in an aluminum chloride-induced rat model of Alzheimer\u2019s disease. Physiol Rep 12:e16095","journal-title":"Physiol Rep"},{"key":"5857_CR171","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/pharmaceutics12040311","volume":"12","author":"D Kim","year":"2020","unstructured":"Kim D, Han TH, Hong S-C et al (2020) PLGA microspheres with alginate-coated large pores for the formulation of an injectable depot of donepezil hydrochloride. Pharmaceutics 12:311","journal-title":"Pharmaceutics"},{"key":"5857_CR172","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/00222348.2013.874310","volume":"53","author":"E Bulut","year":"2014","unstructured":"Bulut E, \u015eanli O (2014) Optimization of release conditions of Alzheimer\u2019s drug donepezil hydrochloride from sodium alginate\/sodium carboxymethyl cellulose blend microspheres. J Macromol Sci B 53:902\u2013917","journal-title":"J Macromol Sci B"},{"key":"5857_CR173","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1186\/1743-8454-6-S2-S15","volume":"6","author":"K Harmening","year":"2009","unstructured":"Harmening K, Heile A, Miller M et al (2009) Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer\u2019s disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells. Cerebrospinal Fluid Research 6:S15","journal-title":"Cerebrospinal Fluid Research"},{"key":"5857_CR174","doi-asserted-by":"crossref","unstructured":"Ali A, Ahmed S (2018) Carrageenans: structure, properties and applications. In: Marine polysaccharides. Jenny Stanford Publishing, pp 29\u201352","DOI":"10.1201\/9780429058929-3"},{"key":"5857_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.119045","volume":"281","author":"A Jafari","year":"2022","unstructured":"Jafari A, Farahani M, Sedighi M et al (2022) Carrageenans for tissue engineering and regenerative medicine applications: a review. Carbohyd Polym 281:119045","journal-title":"Carbohyd Polym"},{"key":"5857_CR176","doi-asserted-by":"crossref","unstructured":"Kondaveeti SB, Tripathi AK, Kumar D, Kumar A, Singh TG, Mahmood S, Ghosal K, Awasthi A, Kumar M (2025) Signalling pathways triggering therapeutic marine algae-derived natural polysaccharides for effective wound healing: a recent review. Carbohydr Polym 22:124253","DOI":"10.1016\/j.carbpol.2025.124253"},{"key":"5857_CR177","doi-asserted-by":"publisher","first-page":"187","DOI":"10.17221\/6758-VETMED","volume":"58","author":"J Necas","year":"2013","unstructured":"Necas J, Bartosikova L (2013) Carrageenan: a review. Veterinarni Med 58:187\u2013205","journal-title":"Veterinarni Med"},{"key":"5857_CR178","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/md18020097","volume":"18","author":"R du Preez","year":"2020","unstructured":"du Preez R, Paul N, Mouatt P et al (2020) Carrageenans from the red seaweed Sarconema filiforme attenuate symptoms of diet-induced metabolic syndrome in rats. Mar Drugs 18:97","journal-title":"Mar Drugs"},{"key":"5857_CR179","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/md18070347","volume":"18","author":"MA Hannan","year":"2020","unstructured":"Hannan MA, Dash R, Haque MN et al (2020) Neuroprotective potentials of marine algae and their bioactive metabolites: pharmacological insights and therapeutic advances. Mar Drugs 18:347","journal-title":"Mar Drugs"},{"key":"5857_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28010002","volume":"28","author":"M Elbandy","year":"2022","unstructured":"Elbandy M (2022) Anti-inflammatory effects of marine bioactive compounds and their potential as functional food ingredients in the prevention and treatment of neuroinflammatory disorders. Molecules 28:2","journal-title":"Molecules"},{"key":"5857_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/md23070274","volume":"23","author":"T Wang","year":"2025","unstructured":"Wang T, Shi W, Mao Z et al (2025) Neuroprotective mechanisms of red algae-derived bioactive compounds in Alzheimer\u2019s disease: an overview of novel insights. Mar Drugs 23:274","journal-title":"Mar Drugs"},{"key":"5857_CR182","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03443-6","author":"Z Yao","year":"2022","unstructured":"Yao Z, Xu L, Jin L et al (2022) \u03ba-carrageenan oligosaccharides inhibit the inflammation of lipopolysaccharide-activated microglia via TLR4\/NF-\u03baB and p38\/JNK MAPKs pathways. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-021-03443-6","journal-title":"Neurochem Res"},{"key":"5857_CR183","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/ijms20123061","volume":"20","author":"MC Barbalace","year":"2019","unstructured":"Barbalace MC, Malaguti M, Giusti L et al (2019) Anti-inflammatory activities of marine algae in neurodegenerative diseases. Int J Mol Sci 20:3061","journal-title":"Int J Mol Sci"},{"key":"5857_CR184","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18:918\u2013935","journal-title":"Curr Neuropharmacol"},{"key":"5857_CR185","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3390\/plants12132445","volume":"12","author":"EA Flores-Contreras","year":"2023","unstructured":"Flores-Contreras EA, Ara\u00fajo RG, Rodr\u00edguez-Aguayo AA et al (2023) Polysaccharides from the Sargassum and brown algae genus: extraction, purification, and their potential therapeutic applications. Plants 12:2445","journal-title":"Plants"},{"key":"5857_CR186","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1039\/C8MT00203G","volume":"11","author":"M Rana","year":"2019","unstructured":"Rana M, Sharma AK (2019) Cu and Zn interactions with A\u03b2 peptides: consequence of coordination on aggregation and formation of neurotoxic soluble A\u03b2 oligomers. Metallomics 11:64\u201384","journal-title":"Metallomics"},{"key":"5857_CR187","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/md17120674","volume":"17","author":"Q Zhong","year":"2019","unstructured":"Zhong Q, Wei B, Wang S et al (2019) The antioxidant activity of polysaccharides derived from marine organisms: an overview. Mar Drugs 17:674","journal-title":"Mar Drugs"},{"key":"5857_CR188","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/md17100590","volume":"17","author":"GPE Saraswati","year":"2019","unstructured":"Saraswati GPE, Iskandriati D et al (2019) Sargassum seaweed as a source of anti-inflammatory substances and the potential insight of the tropical species: a review. Mar Drugs 17:590","journal-title":"Mar Drugs"},{"key":"5857_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"R-H Shih","year":"2015","unstructured":"Shih R-H, Wang C-Y, Yang C-M (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77","journal-title":"Front Mol Neurosci"},{"key":"5857_CR190","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s11064-024-04107-x","volume":"49","author":"L-J Zhang","year":"2024","unstructured":"Zhang L-J, Zhang H-Z, Liu Y-W et al (2024) Sulphated Fucooligosaccharide from Sargassum horneri: structural analysis and anti-Alzheimer activity. Neurochem Res 49:1592\u20131602","journal-title":"Neurochem Res"},{"key":"5857_CR191","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.carbpol.2015.12.019","volume":"139","author":"P Hu","year":"2016","unstructured":"Hu P, Li Z, Chen M et al (2016) Structural elucidation and protective role of a polysaccharide from Sargassum fusiforme on ameliorating learning and memory deficiencies in mice. Carbohyd Polym 139:150\u2013158","journal-title":"Carbohyd Polym"},{"key":"5857_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41399-4","volume":"9","author":"J Bogie","year":"2019","unstructured":"Bogie J, Hoeks C, Schepers M et al (2019) Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer\u2019s disease mouse model. Sci Rep 9:4908","journal-title":"Sci Rep"},{"key":"5857_CR193","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13765-025-01054-1","volume":"68","author":"K Promyo","year":"2025","unstructured":"Promyo K, Cho A-R, Song D et al (2025) Effects of brown algae (Sargassum thunbergii and Sargassum fusiforme) on the progression of some characteristics of Alzheimer\u2019s disease and microglial dysfunction in D-galactose-induced aging rat. Applied Biological Chemistry 68:82","journal-title":"Applied Biological Chemistry"},{"key":"5857_CR194","doi-asserted-by":"publisher","DOI":"10.4490\/algae.2023.38.12.1","author":"DP Nagahawatta","year":"2023","unstructured":"Nagahawatta DP, Liyanage NM, Jayawardena TU et al (2023) Functions and values of sulfated polysaccharides from seaweed. Algae. https:\/\/doi.org\/10.4490\/algae.2023.38.12.1","journal-title":"Algae"},{"key":"5857_CR195","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/md17030183","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xing M, Cao Q et al (2019) Biological activities of fucoidan and the factors mediating its therapeutic effects: a review of recent studies. Mar Drugs 17:183","journal-title":"Mar Drugs"},{"key":"5857_CR196","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.joca.2010.01.016","volume":"18","author":"J Egea","year":"2010","unstructured":"Egea J, Garc\u00eda AG, Verges J et al (2010) Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. Osteoarthritis Cartilage 18:S24\u2013S27","journal-title":"Osteoarthritis Cartilage"},{"key":"5857_CR197","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/md23090350","volume":"23","author":"C Yang","year":"2025","unstructured":"Yang C, Dwan C, Wimmer BC et al (2025) Anti-inflammatory and neuroprotective effects of Undaria pinnatifida fucoidan. Mar Drugs 23:350","journal-title":"Mar Drugs"},{"key":"5857_CR198","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.fct.2011.04.020","volume":"49","author":"HY Park","year":"2011","unstructured":"Park HY, Han MH, Park C et al (2011) Anti-inflammatory effects of fucoidan through inhibition of NF-\u03baB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem Toxicol 49:1745\u20131752","journal-title":"Food Chem Toxicol"},{"key":"5857_CR199","doi-asserted-by":"crossref","unstructured":"Park SK, Kang JY, Kim JM et al (2021) Ecklonia cava attenuates PM2. 5-induced cognitive decline through mitochondrial activation and anti-inflammatory effect. Mar Drugs 19:131","DOI":"10.3390\/md19030131"},{"key":"5857_CR200","doi-asserted-by":"publisher","DOI":"10.3390\/md18050242","volume":"18","author":"J Dimitrova-Shumkovska","year":"2020","unstructured":"Dimitrova-Shumkovska J, Krstanoski L, Veenman L (2020) Potential beneficial actions of fucoidan in brain and liver injury, disease, and intoxication\u2014potential implication of sirtuins. Mar Drugs 18:242","journal-title":"Mar Drugs"},{"key":"5857_CR201","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijbiomac.2015.01.003","volume":"74","author":"M Wozniak","year":"2015","unstructured":"Wozniak M, Bell T, D\u00e9nes \u00c1 et al (2015) Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer\u2019s disease. Int J Biol Macromol 74:530\u2013540","journal-title":"Int J Biol Macromol"},{"key":"5857_CR202","first-page":"1","volume":"12","author":"M Subaraja","year":"2020","unstructured":"Subaraja M, Krishnan DA, Hillary VE et al (2020) Fucoidan serves a neuroprotective effect in an Alzheimer\u2019s disease model. Frontiers in Bioscience-Elite 12:1\u201334","journal-title":"Frontiers in Bioscience-Elite"},{"key":"5857_CR203","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.etap.2011.12.022","volume":"33","author":"Y Gao","year":"2012","unstructured":"Gao Y, Li C, Yin J et al (2012) Fucoidan, a sulfated polysaccharide from brown algae, improves cognitive impairment induced by infusion of A\u03b2 peptide in rats. Environ Toxicol Pharmacol 33:304\u2013311","journal-title":"Environ Toxicol Pharmacol"},{"key":"5857_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-25869-6","volume":"15","author":"M Salmani","year":"2025","unstructured":"Salmani M, Anoush M, Kalantari-Hesari A et al (2025) Protective role of fucoidan against cognitive deficits and redox imbalance in a scopolamine-induced Alzheimer\u2019s disease model in rats. Sci Rep 15:41813","journal-title":"Sci Rep"},{"key":"5857_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2019.101422","volume":"39","author":"JT Kidgell","year":"2019","unstructured":"Kidgell JT, Magnusson M, de Nys R, Glasson CRK (2019) Ulvan: a systematic review of extraction, composition and function. Algal Res 39:101422","journal-title":"Algal Res"},{"key":"5857_CR206","doi-asserted-by":"crossref","unstructured":"Usman A, Khalid S, Usman A, Hussain Z, Wang Y (2017) Algal polysaccharides, novel application, and outlook. In: Algae based polymers, blends, and composites. Elsevier, pp 115\u2013153","DOI":"10.1016\/B978-0-12-812360-7.00005-7"},{"key":"5857_CR207","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/cancers15030715","volume":"15","author":"PP Bhuyan","year":"2023","unstructured":"Bhuyan PP, Nayak R, Patra S et al (2023) Seaweed-derived sulfated polysaccharides; the new age chemopreventives: a comprehensive review. Cancers 15:715","journal-title":"Cancers"},{"key":"5857_CR208","doi-asserted-by":"crossref","unstructured":"Kumar PM, Janani R, Priya S, Naveen J, Baskaran V (2022) Pharmaceutical applications of major marine nutraceuticals: astaxanthin, fucoxanthin, ulvan, and polyphenols. In: Marine biochemistry. CRC Press, pp 315\u2013335","DOI":"10.1201\/9781003303909-17"},{"key":"5857_CR209","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12017-011-8155-9","volume":"13","author":"Z Cai","year":"2011","unstructured":"Cai Z, Zhao B, Ratka A (2011) Oxidative stress and \u03b2-amyloid protein in Alzheimer\u2019s disease. Neuromol Med 13:223\u2013250","journal-title":"Neuromol Med"},{"key":"5857_CR210","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pathophys.2006.05.004","volume":"13","author":"V Chauhan","year":"2006","unstructured":"Chauhan V, Chauhan A (2006) Oxidative stress in Alzheimer\u2019s disease. Pathophysiology 13:195\u2013208","journal-title":"Pathophysiology"},{"key":"5857_CR211","doi-asserted-by":"publisher","first-page":"41167","DOI":"10.1021\/acsami.0c14292","volume":"12","author":"F Liu","year":"2020","unstructured":"Liu F, Zhao W, Zhao F et al (2020) Dual effect of the acidic polysaccharose ulvan on the inhibition of amyloid-\u03b2 protein fibrillation and disintegration of mature fibrils. ACS Appl Mater Interfaces 12:41167\u201341176","journal-title":"ACS Appl Mater Interfaces"},{"key":"5857_CR212","doi-asserted-by":"publisher","first-page":"205","DOI":"10.59249\/JNKB9714","volume":"97","author":"JY Lee","year":"2024","unstructured":"Lee JY, Wong CY, Koh RY et al (2024) Natural bioactive compounds from macroalgae and microalgae for the treatment of Alzheimer\u2019s disease: a review. Yale J Biol Med 97:205","journal-title":"Yale J Biol Med"},{"key":"5857_CR213","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ijms25020797","volume":"25","author":"J Cotas","year":"2024","unstructured":"Cotas J, Lomartire S, Gon\u00e7alves AMM, Pereira L (2024) From ocean to medicine: harnessing seaweed\u2019s potential for drug development. Int J Mol Sci 25:797","journal-title":"Int J Mol Sci"},{"key":"5857_CR214","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.52711\/0974-360X.2023.00965","volume":"16","author":"KN Kumari","year":"2023","unstructured":"Kumari KN, Jeyabalan S, Rajangam J et al (2023) Neuroprotective potential of total extract of Ulva lactuca: an in vitro study. Res J Pharm Technol 16:5948\u20135953","journal-title":"Res J Pharm Technol"},{"key":"5857_CR215","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/polym16101351","volume":"16","author":"SM Mawazi","year":"2024","unstructured":"Mawazi SM, Kumar M, Ahmad N et al (2024) Recent applications of chitosan and its derivatives in antibacterial, anticancer, wound healing, and tissue engineering fields. Polymers 16:1351","journal-title":"Polymers"},{"key":"5857_CR216","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.32604\/jrm.2022.018142","volume":"10","author":"BT Iber","year":"2022","unstructured":"Iber BT, Kasan NA, Torsabo D, Omuwa JW (2022) A review of various sources of chitin and chitosan in nature. J Renew Mater 10:1097","journal-title":"J Renew Mater"},{"key":"5857_CR217","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10126-005-0097-5","volume":"8","author":"K Kurita","year":"2006","unstructured":"Kurita K (2006) Chitin and chitosan: functional biopolymers from marine crustaceans. Mar Biotechnol 8:203\u2013226","journal-title":"Mar Biotechnol"},{"key":"5857_CR218","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.matpr.2023.05.729","volume":"88","author":"AO Adeyemi","year":"2023","unstructured":"Adeyemi AO, Ojoawo SO (2023) Production and characterization of chitosan of crustacean shells. Mater Today Proc 88:128\u2013134","journal-title":"Mater Today Proc"},{"key":"5857_CR219","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/molecules29132962","volume":"29","author":"O Amamou","year":"2024","unstructured":"Amamou O, Kefil S, Denis J-P et al (2024) Revisiting the determination of the degree of deacetylation using potentiometric titration: a new equation for modified chitosan. Molecules 29:2962","journal-title":"Molecules"},{"key":"5857_CR220","first-page":"3","volume":"12","author":"S Saini","year":"2022","unstructured":"Saini S, Nanda S, Dhiman A (2022) Chitosan nanoparticles: an approbative system for the delivery of herbal bioactives. Nat Prod J 12:3\u201316","journal-title":"Nat Prod J"},{"key":"5857_CR221","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijbiomac.2015.11.011","volume":"83","author":"S Jia","year":"2016","unstructured":"Jia S, Lu Z, Gao Z et al (2016) Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-\u03b21\u201342-induced rat model of Alzheimer\u2019s disease. Int J Biol Macromol 83:416\u2013425","journal-title":"Int J Biol Macromol"},{"key":"5857_CR222","doi-asserted-by":"crossref","unstructured":"Peptu C, Humelnicu AC, Rotaru R, Fortuna ME, Patras X, Teodorescu M, Tamba BI, Harabagiu V (2019) Chitosan-based drug delivery systems. In: Chitin and Chitosan: properties and applications, vol 31, pp 259\u2013289","DOI":"10.1002\/9781119450467.ch11"},{"key":"5857_CR223","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15171\/apb.2019.023","volume":"9","author":"U Garg","year":"2019","unstructured":"Garg U, Chauhan S, Nagaich U, Jain N (2019) Current advances in chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull 9:195","journal-title":"Adv Pharm Bull"},{"key":"5857_CR224","doi-asserted-by":"publisher","first-page":"10916","DOI":"10.1007\/s12035-024-04256-8","volume":"61","author":"R Singh","year":"2024","unstructured":"Singh R, Panghal A, Jadhav K et al (2024) Recent advances in targeting transition metals (copper, iron, and zinc) in Alzheimer\u2019s disease. Mol Neurobiol 61:10916\u201310940","journal-title":"Mol Neurobiol"},{"key":"5857_CR225","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/acs.biomac.5b00603","volume":"16","author":"H Liu","year":"2015","unstructured":"Liu H, Ojha B, Morris C et al (2015) Positively charged chitosan and N-trimethyl chitosan inhibit A\u03b240 fibrillogenesis. Biomacromol 16:2363\u20132373","journal-title":"Biomacromol"},{"key":"5857_CR226","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000519534","volume":"81","author":"M Amini","year":"2022","unstructured":"Amini M, Abdolmaleki Z (2022) The effect of cannabidiol coated by nano-chitosan on learning and memory, hippocampal CB1 and CB2 levels, and amyloid plaques in an Alzheimer\u2019s disease rat model. Neuropsychobiology 81:171\u2013183","journal-title":"Neuropsychobiology"},{"key":"5857_CR227","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1021\/acschemneuro.2c00240","volume":"13","author":"S Saleem","year":"2022","unstructured":"Saleem S, Banerjee R, Rajesh Kannan R (2022) Chrysin-loaded chitosan nanoparticle-mediated neuroprotection in A\u03b21\u201342-induced neurodegenerative conditions in zebrafish. ACS Chem Neurosci 13:2017\u20132034","journal-title":"ACS Chem Neurosci"},{"key":"5857_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124316","volume":"239","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Zheng G et al (2023) Resveratrol-loaded selenium\/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer\u2019s disease. Int J Biol Macromol 239:124316","journal-title":"Int J Biol Macromol"},{"key":"5857_CR229","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12640-023-00634-7","volume":"41","author":"V Chaudhari","year":"2023","unstructured":"Chaudhari V, Bagwe-Parab S, Buttar HS et al (2023) Challenges and opportunities of metal chelation therapy in trace metals overload-induced Alzheimer\u2019s disease. Neurotox Res 41:270\u2013287","journal-title":"Neurotox Res"},{"key":"5857_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030829","volume":"15","author":"D Georgieva","year":"2023","unstructured":"Georgieva D, Nikolova D, Vassileva E, Kostova B (2023) Chitosan-based nanoparticles for targeted nasal galantamine delivery as a promising tool in Alzheimer\u2019s disease therapy. Pharmaceutics 15:829","journal-title":"Pharmaceutics"},{"key":"5857_CR231","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijbiomac.2013.04.024","volume":"59","author":"K Nagpal","year":"2013","unstructured":"Nagpal K, Singh SK, Mishra DN (2013) Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety. Int J Biol Macromol 59:72\u201383","journal-title":"Int J Biol Macromol"},{"key":"5857_CR232","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1166\/sam.2014.1761","volume":"6","author":"S Md","year":"2014","unstructured":"Md S, Ali M, Bhatnagar A et al (2014) Design, development, optimization and characterization of donepezil loaded chitosan nanoparticles for brain targeting to treat Alzheimer\u2019s disease. Sci Adv Mater 6:720\u2013735","journal-title":"Sci Adv Mater"},{"key":"5857_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, Wang Y, Li Z et al (2023) Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym 310:120714","journal-title":"Carbohydr Polym"},{"key":"5857_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2025.114778","volume":"214","author":"YA Youssef","year":"2025","unstructured":"Youssef YA, Tammam SN, Elshenawy BM et al (2025) Peptide-loaded chitosan nanoparticles improve mitochondrial and cognitive functions via inhibition of A\u03b2-ABAD interaction in Alzheimer\u2019s disease. Eur J Pharm Biopharm 214:114778","journal-title":"Eur J Pharm Biopharm"},{"key":"5857_CR235","doi-asserted-by":"crossref","unstructured":"Orli\u0144ska K, Komosi\u0144ska-Vassev K, Olczyk K, Kowalczyk A, Olczyk P\u00a0(2023)\u00a0Glycosaminoglycans\u2013types, structure, functions, and the role in wound healing processes. In Annales Academiae Medicae Silesiensis 2023 (No. 77). \u015al\u0105ski Uniwersytet Medyczny w Katowicach. Wydawnictwo \u015al\u0105skiego Uniwersytetu Medycznego w Katowicach, pp 204\u2013216","DOI":"10.18794\/aams\/173470"},{"key":"5857_CR236","first-page":"225","volume":"8","author":"B Chakrabarti","year":"1980","unstructured":"Chakrabarti B, Park JW, Stevens ES (1980) Glycosaminoglycans: structure and interactio. Crit Rev Biochem Mol Biol 8:225\u2013313","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5857_CR237","doi-asserted-by":"publisher","unstructured":"Kusindarta DL, Wihadmadyatami H (2018) The role of extracellular matrix in tissue regeneration. Tissue Regen 65. https:\/\/doi.org\/10.5772\/intechopen.75728","DOI":"10.5772\/intechopen.75728"},{"key":"5857_CR238","unstructured":"Casale J, Crane JS (2019) Biochemistry, glycosaminoglycans"},{"key":"5857_CR239","doi-asserted-by":"crossref","unstructured":"Shute J (2011) Glycosaminoglycan and chemokine\/growth factor interactions. In: Heparin-a century of progress, pp 307\u2013324","DOI":"10.1007\/978-3-642-23056-1_13"},{"key":"5857_CR240","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00441-003-0756-7","volume":"313","author":"B Reuss","year":"2003","unstructured":"Reuss B, von Bohlen und Halbach O (2003) Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313:139\u2013157","journal-title":"Cell Tissue Res"},{"key":"5857_CR241","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuron.2012.08.037","volume":"76","author":"CA Turner","year":"2012","unstructured":"Turner CA, Watson SJ, Akil H (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76:160\u2013174","journal-title":"Neuron"},{"key":"5857_CR242","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1271\/bbb.90637","volume":"73","author":"Y Kanato","year":"2009","unstructured":"Kanato Y, Ono S, Kitajima K, Sato C (2009) Complex formation of a brain-derived neurotrophic factor and glycosaminoglycans. Biosci Biotechnol Biochem 73:2735\u20132741","journal-title":"Biosci Biotechnol Biochem"},{"key":"5857_CR243","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1755-5949.2012.00371.x","volume":"18","author":"A Oyagi","year":"2012","unstructured":"Oyagi A, Hara H (2012) Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain. CNS Neurosci Ther 18:803\u2013810","journal-title":"CNS Neurosci Ther"},{"key":"5857_CR244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","volume":"46","author":"MM Nowacka","year":"2012","unstructured":"Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46:1\u201310","journal-title":"Neuropeptides"},{"key":"5857_CR245","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/j.1460-9568.2012.08126.x","volume":"35","author":"PM Pimentel-Coelho","year":"2012","unstructured":"Pimentel-Coelho PM, Rivest S (2012) The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer\u2019s disease. Eur J Neurosci 35:1917\u20131937","journal-title":"Eur J Neurosci"},{"key":"5857_CR246","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0306-4522(92)90521-3","volume":"51","author":"JH Su","year":"1992","unstructured":"Su JH, Cummings BJ, Cotman CW (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer\u2019s disease. Neuroscience 51:801\u2013813","journal-title":"Neuroscience"},{"key":"5857_CR247","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1002\/1873-3468.13082","volume":"592","author":"A Ma\u00efza","year":"2018","unstructured":"Ma\u00efza A, Chantepie S, Vera C et al (2018) The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett 592:3806\u20133818","journal-title":"FEBS Lett"},{"key":"5857_CR248","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroscience.2015.11.040","volume":"313","author":"A Suttkus","year":"2016","unstructured":"Suttkus A, Holzer M, Morawski M, Arendt T (2016) The neuronal extracellular matrix restricts distribution and internalization of aggregated Tau-protein. Neuroscience 313:225\u2013235","journal-title":"Neuroscience"},{"key":"5857_CR249","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N et al (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110:E3138\u2013E3147","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5857_CR250","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1515\/revneuro-2020-0146","volume":"32","author":"J Lin","year":"2021","unstructured":"Lin J, Duan M, Lin N, Zhao W (2021) The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases. Rev Neurosci 32:737\u2013750","journal-title":"Rev Neurosci"},{"key":"5857_CR251","doi-asserted-by":"crossref","unstructured":"Schwartz NB, Domowicz MS (2014) Chemistry and function of glycosaminoglycans in the nervous system. In: Glycobiology of the nervous system, vol 18, pp 89\u2013115","DOI":"10.1007\/978-1-4939-1154-7_5"},{"key":"5857_CR252","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/jasms.4c00159","volume":"35","author":"M Sarbu","year":"2024","unstructured":"Sarbu M, Seidler DG, Clemmer DE, Zamfir AD (2024) Introducing ion mobility mass spectrometry in brain glycosaminoglycomics: application to chondroitin\/dermatan sulfate octasaccharide domains. J Am Soc Mass Spectrom 35:2102\u20132117","journal-title":"J Am Soc Mass Spectrom"},{"key":"5857_CR253","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/j.1582-4934.2009.00826.x","volume":"13","author":"P du Souich","year":"2009","unstructured":"du Souich P, Garc\u00eda AG, Verg\u00e9s J, Montell E (2009) Immunomodulatory and anti\u2010inflammatory effects of chondroitin sulphate. J Cell Mol Med 13:1451\u20131463","journal-title":"J Cell Mol Med"},{"key":"5857_CR254","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen Z-R, Huang J-B, Yang S-L, Hong F-F (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27:1816","journal-title":"Molecules"},{"key":"5857_CR255","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/exnr.1993.1081","volume":"121","author":"DA Dewitt","year":"1993","unstructured":"Dewitt DA, Silver J, Canning DR, Perry G (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer\u2019s disease. Exp Neurol 121:149\u2013152","journal-title":"Exp Neurol"},{"key":"5857_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131425","volume":"266","author":"J Tian","year":"2024","unstructured":"Tian J, Peng Q, Shen Y et al (2024) Chondroitin sulphate modified MoS2 nanoenzyme with multifunctional activities for treatment of Alzheimer\u2019s disease. Int J Biol Macromol 266:131425","journal-title":"Int J Biol Macromol"},{"key":"5857_CR257","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0306-4522(99)00071-8","volume":"92","author":"G Br\u00fcckner","year":"1999","unstructured":"Br\u00fcckner G, Hausen D, H\u00e4rtig W et al (1999) Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer\u2019s disease. Neuroscience 92:791\u2013805","journal-title":"Neuroscience"},{"key":"5857_CR258","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijbiomac.2020.03.079","volume":"154","author":"D Ji","year":"2020","unstructured":"Ji D, Wu X, Li D et al (2020) Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer\u2019s disease. Int J Biol Macromol 154:233\u2013245","journal-title":"Int J Biol Macromol"},{"key":"5857_CR259","doi-asserted-by":"publisher","first-page":"13819","DOI":"10.1016\/S0021-9258(19)49641-5","volume":"267","author":"J Shioi","year":"1992","unstructured":"Shioi J, Anderson JP, Ripellino JA, Robakis NK (1992) Chondroitin sulfate proteoglycan form of the Alzheimer\u2019s beta-amyloid precursor. J Biol Chem 267:13819\u201313822","journal-title":"J Biol Chem"},{"key":"5857_CR260","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/glycob\/cwaa096","volume":"31","author":"N Zhao","year":"2021","unstructured":"Zhao N, Meng J, Jiang W et al (2021) Study on the relationships between molecular weights of chondroitin sulfate oligosaccharides and A\u03b2-induced oxidative stress and the related mechanisms. Glycobiology 31:492\u2013507","journal-title":"Glycobiology"},{"key":"5857_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108796","volume":"199","author":"N Zhao","year":"2021","unstructured":"Zhao N, Wu L, Zhang X et al (2021) Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain. Neuropharmacology 199:108796","journal-title":"Neuropharmacology"},{"key":"5857_CR262","doi-asserted-by":"crossref","unstructured":"Radhouani H, Correia S, Gon\u00e7alves C et al (2021) Glycosaminoglycans. In: Polysaccharides of Microbial Origin: Biomed Appl. Springer, pp 1\u201318","DOI":"10.1007\/978-3-030-35734-4_12-1"},{"key":"5857_CR263","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.3390\/molecules26175211","volume":"26","author":"LCGF Palhares","year":"2021","unstructured":"Palhares LCGF, London JA, Kozlowski AM et al (2021) Chemical modification of glycosaminoglycan polysaccharides. Molecules 26:5211","journal-title":"Molecules"},{"key":"5857_CR264","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/jnr.22393","volume":"88","author":"T Ariga","year":"2010","unstructured":"Ariga T, Miyatake T, Yu RK (2010) Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer\u2019s disease and related disorders: amyloidogenesis and therapeutic strategies\u2014a review. J Neurosci Res 88:2303\u20132315","journal-title":"J Neurosci Res"},{"key":"5857_CR265","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.710683","volume":"13","author":"AD Snow","year":"2021","unstructured":"Snow AD, Cummings JA, Lake T (2021) The unifying hypothesis of Alzheimer\u2019s disease: heparan sulfate proteoglycans\/glycosaminoglycans are key as first hypothesized over 30 years ago. Front Aging Neurosci 13:710683","journal-title":"Front Aging Neurosci"},{"key":"5857_CR266","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0046-8177(87)80036-9","volume":"18","author":"AD Snow","year":"1987","unstructured":"Snow AD, Willmer JP, Kisilevsky R (1987) Sulfated glycosaminoglycans in Alzheimer\u2019s disease. Hum Pathol 18:506\u2013510","journal-title":"Hum Pathol"},{"key":"5857_CR267","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202212636","volume":"135","author":"D Mah","year":"2023","unstructured":"Mah D, Zhu Y, Su G et al (2023) Apolipoprotein E recognizes Alzheimer\u2019s disease associated 3-O sulfation of heparan sulfate. Angew Chem 135:e202212636","journal-title":"Angew Chem"},{"key":"5857_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119205","volume":"285","author":"L Wu","year":"2022","unstructured":"Wu L, Jiang W, Zhao N, Wang F (2022) Heparan sulfate from porcine mucosa promotes amyloid-beta clearance in APP\/PS1 mice and alleviates Alzheimer\u2019s pathology. Carbohydr Polym 285:119205","journal-title":"Carbohydr Polym"},{"key":"5857_CR269","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1021\/acs.jmedchem.4c02563","volume":"68","author":"S Zhu","year":"2025","unstructured":"Zhu S, Song Z, Tapayan AS et al (2025) Effects of heparan sulfate trisaccharide containing oleanolic acid in attenuating hyperphosphorylated tau-induced cell dysfunction associated with Alzheimer\u2019s disease. J Med Chem 68:3356\u20133372","journal-title":"J Med Chem"},{"key":"5857_CR270","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101518","volume":"11","author":"A Marinho","year":"2021","unstructured":"Marinho A, Nunes C, Reis S (2021) Hyaluronic acid: a key ingredient in the therapy of inflammation. Biomolecules 11:1518","journal-title":"Biomolecules"},{"key":"5857_CR271","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.3390\/polym14173442","volume":"14","author":"C Buckley","year":"2022","unstructured":"Buckley C, Murphy EJ, Montgomery TR, Major I (2022) Hyaluronic acid: a review of the drug delivery capabilities of this naturally occurring polysaccharide. Polymers 14:3442","journal-title":"Polymers"},{"key":"5857_CR272","doi-asserted-by":"publisher","first-page":"14372","DOI":"10.3390\/ijms232214372","volume":"23","author":"A Di Mola","year":"2022","unstructured":"Di Mola A, Landi MR, Massa A et al (2022) Hyaluronic acid in biomedical fields: new trends from chemistry to biomaterial applications. Int J Mol Sci 23:14372","journal-title":"Int J Mol Sci"},{"key":"5857_CR273","doi-asserted-by":"crossref","unstructured":"Bhattacharjee S, Harithasree V, Mourya A, Babu CK, Bahuguna D, Devangan P, Sainaga Jyothi VG, Shetiya A, Jain AK, Singh SB, Madan J (2024) Hyaluronic acid hydrogel in therapeutics delivery and biomedical applications. In: Biomaterial-based hydrogels: therapeutics carrier and tissue regeneration. Springer Nature Singapore, Singapore, pp 139\u2013177","DOI":"10.1007\/978-981-99-8826-6_6"},{"key":"5857_CR274","first-page":"2046","volume":"4","author":"W Afzal","year":"2025","unstructured":"Afzal W, Afshan H, Inam J et al (2025) Targeting \u03b2-amyloid in Alzheimer\u2019s disease: a molecular dynamics study of myricetin as a natural inhibitor. Pakistan Journal of Medical & Cardiological Review 4:2046\u20132074","journal-title":"Pakistan Journal of Medical & Cardiological Review"},{"key":"5857_CR275","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1039\/D3MA00736G","volume":"5","author":"AN Galindo","year":"2024","unstructured":"Galindo AN, Rubio DAF, Hettiaratchi MH (2024) Biomaterial strategies for regulating the neuroinflammatory response. Mater Adv 5:4025\u20134054","journal-title":"Mater Adv"},{"key":"5857_CR276","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/bm050867v","volume":"7","author":"L \u0160olt\u00e9s","year":"2006","unstructured":"\u0160olt\u00e9s L, Mendichi R, Kogan G et al (2006) Degradative action of reactive oxygen species on hyaluronan. Biomacromol 7:659\u2013668","journal-title":"Biomacromol"},{"key":"5857_CR277","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.609073","volume":"13","author":"MR Brown","year":"2020","unstructured":"Brown MR, Radford SE, Hewitt EW (2020) Modulation of \u03b2-amyloid fibril formation in Alzheimer\u2019s disease by microglia and infection. Front Mol Neurosci 13:609073","journal-title":"Front Mol Neurosci"},{"key":"5857_CR278","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/156720510790691074","volume":"7","author":"S Genedani","year":"2010","unstructured":"Genedani S, Agnati LF, Leo G et al (2010) \u03b2-amyloid fibrillation and\/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 7:150\u2013157","journal-title":"Curr Alzheimer Res"},{"key":"5857_CR279","doi-asserted-by":"crossref","unstructured":"Ceylan S, Guner M, Okyar-Bas A, Kahyaoglu Z, Koc NS, Koksal GN, Kiran Y, Sagir A, Balci C, Halil MG, Cankurtaran M (2024) An atherosclerosis indicator hyaluronic acid: can plasma hyaluronic acid be useful in diagnosing Alzheimer's disease? Clin Lab 70(3)","DOI":"10.7754\/Clin.Lab.2023.230734"},{"key":"5857_CR280","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-1043","volume":"20","author":"S Lin","year":"2025","unstructured":"Lin S, Ye Y, Lin S (2025) Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer\u2019s disease. Open Life Sci 20:20221043","journal-title":"Open Life Sci"},{"key":"5857_CR281","first-page":"1934","volume":"113","author":"HF Salem","year":"2024","unstructured":"Salem HF, Aboud HM, Abdellatif MM, Abou-Taleb HA (2024) Nose-to-brain targeted delivery of donepezil hydrochloride via novel hyaluronic acid-doped nanotransfersomes for Alzheimer\u2019s disease mitigation. J Pharm Sci 113:1934\u20131945","journal-title":"J Pharm Sci"},{"key":"5857_CR282","doi-asserted-by":"publisher","first-page":"55879","DOI":"10.1021\/acsami.1c17267","volume":"13","author":"W Wang","year":"2021","unstructured":"Wang W, Liu M, Gao W et al (2021) Coassembled chitosan\u2013hyaluronic acid nanoparticles as a theranostic agent targeting Alzheimer\u2019s \u03b2-amyloid. ACS Appl Mater Interfaces 13:55879\u201355889","journal-title":"ACS Appl Mater Interfaces"},{"key":"5857_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119309","volume":"582","author":"SY Lee","year":"2020","unstructured":"Lee SY, Park J-H, Yang M et al (2020) Ferrous sulfate-directed dual-cross-linked hyaluronic acid hydrogels with long-term delivery of donepezil. Int J Pharm 582:119309","journal-title":"Int J Pharm"},{"key":"5857_CR284","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijbiomac.2019.09.098","volume":"142","author":"F Gao","year":"2020","unstructured":"Gao F, Zhao J, Liu P et al (2020) Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer\u2019s disease. Int J Biol Macromol 142:265\u2013276","journal-title":"Int J Biol Macromol"},{"key":"5857_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.123125","volume":"230","author":"Y Feng","year":"2023","unstructured":"Feng Y, Li X, Ji D et al (2023) Functionalised penetrating peptide-chondroitin sulphate-gold nanoparticles: synthesis, characterization, and applications as an anti-Alzheimer\u2019s disease drug. Int J Biol Macromol 230:123125","journal-title":"Int J Biol Macromol"},{"key":"5857_CR286","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuroscience.2015.08.002","volume":"305","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Li J, Liu C et al (2015) Protective effects of low molecular weight chondroitin sulfate on amyloid beta (A\u03b2)-induced damage in vitro and in vivo. Neuroscience 305:169\u2013182","journal-title":"Neuroscience"},{"key":"5857_CR287","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5530\/jyp.2015.1.6","volume":"7","author":"N Tamilselvan","year":"2015","unstructured":"Tamilselvan N, Raghavan CV (2015) Formulation and characterization of anti Alzheimer\u2019s drug loaded chitosan nanoparticles and its in vitro biological evaluation. J Young Pharm 7:28","journal-title":"J Young Pharm"},{"key":"5857_CR288","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/1061186X.2020.1817041","volume":"29","author":"S Zameer","year":"2021","unstructured":"Zameer S, Ali J, Vohora D et al (2021) Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer\u2019s disease in intracerebroventricular streptozotocin model for brain delivery. J Drug Target 29:199\u2013216","journal-title":"J Drug Target"},{"key":"5857_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148548","author":"KK Abla","year":"2025","unstructured":"Abla KK, Torossian T, Ammar J et al (2025) Double-layered nano vesicular chitosan-coated liposomal system loaded with donepezil cargo for Alzheimer\u2019s disease: design, optimization, and in vivo evaluation. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148548","journal-title":"Int J Biol Macromol"},{"key":"5857_CR290","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","volume":"14","author":"H Abbas","year":"2022","unstructured":"Abbas H, El SNS, Youssef NAHA et al (2022) Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: Focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceutics 14:1003","journal-title":"Pharmaceutics"},{"key":"5857_CR291","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/pharmaceutics14030576","volume":"14","author":"MA Elsheikh","year":"2022","unstructured":"Elsheikh MA, El-Feky YA, Al-Sawahli MM et al (2022) A brain-targeted approach to ameliorate memory disorders in a sporadic Alzheimer\u2019s disease mouse model via intranasal luteolin-loaded nanobilosomes. Pharmaceutics 14:576","journal-title":"Pharmaceutics"},{"key":"5857_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111838","volume":"205","author":"S Saini","year":"2021","unstructured":"Saini S, Sharma T, Jain A et al (2021) Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: a preclinical evidence. Colloids Surf, B 205:111838","journal-title":"Colloids Surf, B"},{"key":"5857_CR293","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1111\/j.1460-9568.2005.04111.x","volume":"21","author":"JH Jhamandas","year":"2005","unstructured":"Jhamandas JH, Wie MB, Harris K et al (2005) Fucoidan inhibits cellular and neurotoxic effects of \u03b2-amyloid (A\u03b2) in rat cholinergic basal forebrain neurons. Eur J Neurosci 21:2649\u20132659","journal-title":"Eur J Neurosci"},{"key":"5857_CR294","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1039\/C7FO00662D","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Yi K, Zhao Y (2018) Fucoidan inhibits amyloid-\u03b2-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-\u03b2 and decreasing the production of reactive oxygen species. Food Funct 9:552\u2013560","journal-title":"Food Funct"},{"key":"5857_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2022.103748","volume":"15","author":"X Chen","year":"2022","unstructured":"Chen X, Guo X, Hao S et al (2022) Iron oxide nanoparticles-loaded hyaluronic acid nanogels for MRI-aided Alzheimer\u2019s disease theranostics. Arab J Chem 15:103748","journal-title":"Arab J Chem"},{"key":"5857_CR296","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133742","volume":"275","author":"EM Mosalam","year":"2024","unstructured":"Mosalam EM, Abdel-Bar HM, Elberri AI et al (2024) Enhanced neuroprotective effect of verapamil-loaded hyaluronic acid modified carbon quantum dots in an in-vitro model of amyloid-induced Alzheimer\u2019s disease. Int J Biol Macromol 275:133742","journal-title":"Int J Biol Macromol"},{"key":"5857_CR297","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S381353","volume":"17","author":"KM AbouElhassan","year":"2022","unstructured":"AbouElhassan KM, Sarhan HA, Hussein AK et al (2022) Brain targeting of citicoline sodium via hyaluronic acid-decorated novel nano-transbilosomes for mitigation of Alzheimer\u2019s disease in a rat model: formulation, optimization, in vitro and in vivo assessment. Int J Nanomedicine 17:6347","journal-title":"Int J Nanomedicine"},{"key":"5857_CR298","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/21691401.2014.962741","volume":"44","author":"E Bulut","year":"2016","unstructured":"Bulut E, \u015eanl\u0131 O (2016) Novel ionically crosslinked acrylamide-grafted poly (vinyl alcohol)\/sodium alginate\/sodium carboxymethyl cellulose pH-sensitive microspheres for delivery of Alzheimer\u2019s drug donepezil hydrochloride: preparation and optimization of release conditions. Artif Cells Nanomed Biotechnol 44:431\u2013442","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"5857_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126316","volume":"253","author":"S Boobphahom","year":"2023","unstructured":"Boobphahom S, Rodthongkum N (2023) Graphene oxide-alginate hydrogel-based indicator displacement assay integrated with diaper for non-invasive Alzheimer\u2019s disease screening. Int J Biol Macromol 253:126316","journal-title":"Int J Biol Macromol"},{"key":"5857_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131841","volume":"268","author":"HB Yekeler","year":"2024","unstructured":"Yekeler HB, Guler E, Beato PS et al (2024) Design and in vitro evaluation of curcumin-loaded PLGA nanoparticle-embedded sodium alginate\/gelatin 3D printed scaffolds for Alzheimer\u2019s disease. Int J Biol Macromol 268:131841","journal-title":"Int J Biol Macromol"},{"key":"5857_CR301","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2023.108747","volume":"525","author":"CJ Mycroft-West","year":"2023","unstructured":"Mycroft-West CJ, Devlin AJ, Cooper LC et al (2023) A sulphated glycosaminoglycan extract from Placopecten magellanicus inhibits the Alzheimer\u2019s disease \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE-1). Carbohydr Res 525:108747","journal-title":"Carbohydr Res"},{"key":"5857_CR302","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/md17050293","volume":"17","author":"CJ Mycroft-West","year":"2019","unstructured":"Mycroft-West CJ, Cooper LC, Devlin AJ et al (2019) A glycosaminoglycan extract from portunus pelagicus inhibits BACE1, the \u03b2 secretase implicated in Alzheimer\u2019s disease. Mar Drugs 17:293","journal-title":"Mar Drugs"},{"key":"5857_CR303","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/1061186X.2023.2238250","volume":"31","author":"V Rastogi","year":"2023","unstructured":"Rastogi V, Jain A, Kumar P et al (2023) A critical review on the role of nanotheranostics mediated approaches for targeting \u03b2 amyloid in Alzheimer\u2019s. J Drug Target 31:725\u2013744","journal-title":"J Drug Target"},{"key":"5857_CR304","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10719-018-9833-8","volume":"35","author":"K Nishitsuji","year":"2018","unstructured":"Nishitsuji K (2018) Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases. Glycoconj J 35:387\u2013396","journal-title":"Glycoconj J"},{"key":"5857_CR305","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00163","volume":"6","author":"SM Alavi Naini","year":"2018","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2018) Heparan sulfate as a therapeutic target in tauopathies: insights from zebrafish. Front Cell Dev Biol 6:163","journal-title":"Front Cell Dev Biol"},{"key":"5857_CR306","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.707466","volume":"13","author":"Y Sun","year":"2021","unstructured":"Sun Y, Xu S, Jiang M et al (2021) Role of the extracellular matrix in Alzheimer\u2019s disease. Front Aging Neurosci 13:707466","journal-title":"Front Aging Neurosci"},{"key":"5857_CR307","doi-asserted-by":"publisher","first-page":"P1473","DOI":"10.1016\/j.jalz.2019.06.4115","volume":"15","author":"WS Weidner","year":"2019","unstructured":"Weidner WS, Barbarino P (2019) P4\u2013443: the state of the art of dementia research: new frontiers. Alzheimers Dement 15:P1473\u2013P1473","journal-title":"Alzheimers Dement"},{"key":"5857_CR308","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/md23080315","volume":"23","author":"V Toulis","year":"2025","unstructured":"Toulis V, Marfany G, Mirra S (2025) Marine derived strategies against neurodegeneration. Mar Drugs 23:315","journal-title":"Mar Drugs"},{"key":"5857_CR309","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Dengra B, Bermejo M, Gonz\u00e1lez-\u00c1lvarez I, Gonz\u00e1lez-\u00c1lvarez M (2022) Marine-based biopolymers for central nervous system drug delivery. In: Marine biomaterials: drug delivery and therapeutic applications. Springer Nature Singapore, Singapore, pp 317\u2013349","DOI":"10.1007\/978-981-16-4787-1_10"},{"key":"5857_CR310","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17460441.2019.1667329","volume":"15","author":"R Cacabelos","year":"2020","unstructured":"Cacabelos R (2020) How plausible is an Alzheimer\u2019s disease vaccine? Expert Opin Drug Discov 15:1\u20136","journal-title":"Expert Opin Drug Discov"},{"key":"5857_CR311","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.614828","volume":"14","author":"N Reich","year":"2020","unstructured":"Reich N, H\u00f6lscher C (2020) Acylated ghrelin as a multi-targeted therapy for Alzheimer\u2019s and Parkinson\u2019s disease. Front Neurosci 14:614828","journal-title":"Front Neurosci"},{"key":"5857_CR312","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3389\/fphar.2019.01679","volume":"10","author":"JR Cabrera-Pardo","year":"2020","unstructured":"Cabrera-Pardo JR, Fuentealba J, Gavil\u00e1n J et al (2020) Exploring the multi\u2013target neuroprotective chemical space of benzofuran scaffolds: a new strategy in drug development for Alzheimer\u2019s disease. Front Pharmacol 10:1679","journal-title":"Front Pharmacol"},{"key":"5857_CR313","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/md20010075","volume":"20","author":"E Lima","year":"2022","unstructured":"Lima E, Medeiros J (2022) Marine organisms as alkaloid biosynthesizers of potential anti-Alzheimer agents. Mar Drugs 20:75","journal-title":"Mar Drugs"},{"key":"5857_CR314","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00702-012-0948-y","volume":"120","author":"I Bolea","year":"2013","unstructured":"Bolea I, Gella A, Unzeta M (2013) Propargylamine-derived multitarget-directed ligands: fighting Alzheimer\u2019s disease with monoamine oxidase inhibitors. J Neural Transm 120:893\u2013902","journal-title":"J Neural Transm"},{"key":"5857_CR315","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/acschemneuro.1c00182","volume":"12","author":"Z Xuan","year":"2021","unstructured":"Xuan Z, Gu X, Yan S et al (2021) Dimeric Tacrine (10)-hupyridone as a multitarget-directed ligand to treat Alzheimer\u2019s disease. ACS Chem Neurosci 12:2462\u20132477","journal-title":"ACS Chem Neurosci"},{"key":"5857_CR316","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/md18100488","volume":"18","author":"L Zhu","year":"2020","unstructured":"Zhu L, Li R, Jiao S et al (2020) Blood-brain barrier permeable chitosan oligosaccharides interfere with \u03b2-amyloid aggregation and alleviate \u03b2-amyloid protein mediated neurotoxicity and neuroinflammation in a dose-and degree of polymerization-dependent manner. Mar Drugs 18:488","journal-title":"Mar Drugs"},{"key":"5857_CR317","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149715","volume":"11","author":"V Makani","year":"2016","unstructured":"Makani V, Jang Y, Christopher K et al (2016) BBB-permeable, neuroprotective, and neurotrophic polysaccharide, midi-GAGR. PLoS One 11:e0149715","journal-title":"PLoS One"},{"key":"5857_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2024.112601","author":"T Mazur","year":"2024","unstructured":"Mazur T, Malik M, Bie\u0144ko DC (2024) The impact of chelating compounds on Cu2+, Fe2+\/3+, and Zn2+ ions in Alzheimer\u2019s disease treatment. J Inorg Biochem. https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112601","journal-title":"J Inorg Biochem"},{"key":"5857_CR319","volume-title":"ADME and translational pharmacokinetics\/pharmacodynamics of therapeutic proteins: applications in drug discovery and development","author":"H Zhou","year":"2015","unstructured":"Zhou H, Theil F-P (2015) ADME and translational pharmacokinetics\/pharmacodynamics of therapeutic proteins: applications in drug discovery and development. John Wiley & Sons"},{"key":"5857_CR320","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yrtph.2018.07.009","volume":"98","author":"FR Brennan","year":"2018","unstructured":"Brennan FR, Andrews L, Arulanandam AR et al (2018) Current strategies in the non-clinical safety assessment of biologics: new targets, new molecules, new challenges. Regul Toxicol Pharmacol 98:98\u2013107","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05857-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05857-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05857-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:05:18Z","timestamp":1777262718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05857-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":320,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5857"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05857-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"589"}}